UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________

 

FORM 10‑Q

_______________

 

X    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2017

 

__   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________________ to________________

 

Commission File Number: 1‑10560

 

BENCHMARK ELECTRONICS, INC.

(Exact name of registrant as specified in its charter)

 

 

Texas

74‑2211011

 

(State or other jurisdiction

(I.R.S. Employer

 

of incorporation or organization)

 

Identification No.)

3000 Technology Drive

77515

Angleton, Texas

(Zip Code)

(Address of principal executive offices)

 

 

     

(979) 849‑6550

(Registrant s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes [ Ö ] No [ ]

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes [ Ö ] No [ ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b–2 of the Exchange Act.

 

Large accelerated filer [ Ö

Accelerated filer [   ]

Non-accelerated filer [   ] (Do not check if a smaller reporting company)

Smaller reporting company [   ]

Emerging growth company [   ]

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [ ]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b–2 of the Act). Yes [ ] No [ Ö

 

As of May 5, 2017 there were 49,735,727 shares of Common Stock of Benchmark Electronics, Inc., par value $0.10 per share, outstanding.

 

  

 


 

TABLE OF CONTENTS

 

PART I

 

 

 

 

Page

 

 

 

PART I—FINANCIAL INFORMATION

 

 

 

Item 1.

Financial Statements (Unaudited)

1

 

Condensed Consolidated Balance Sheets

1

 

Condensed Consolidated Statements of Income

2

 

Condensed Consolidated Statements of Comprehensive Income

3

 

Condensed Consolidated Statement of Shareholders’ Equity

4

 

Condensed Consolidated Statements of Cash Flows

5

 

Notes to Condensed Consolidated Financial Statements

6

Item 2.

Management’s Discussion and Analysis of Financial Condition and

19

 

Results of Operations

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

26

Item 4.

Controls and Procedures

27

 

 

 

PART II—OTHER INFORMATION

 

 

 

Item 1.

Legal Proceedings

28

Item 1A.

Risk Factors

28

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

28

Item 6.

Exhibits

29

 

 

SIGNATURES

30

  

 


 

PART I - FINANCIAL INFORMATION

 

Item 1.             Financial Statements.    

BENCHMARK ELECTRONICS, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

  

 

 

 

 

 

 

 

March 31,

 

December 31,

(in thousands, except par value)

 

2017

 

 

2016

 

 

 

 

 

 

(unaudited)

 

 

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents

$

752,477

 

$

681,433

 

 

Accounts receivable, net of allowance for doubtful accounts of $4,535

 

 

 

 

 

 

 

 

and $2,838, respectively

 

381,200

 

 

440,692

 

 

Inventories

 

404,023

 

 

381,334

 

 

Prepaid expenses and other assets

 

34,193

 

 

28,057

 

 

Income taxes receivable

 

1,159

 

 

146

 

 

 

 

Total current assets

 

1,573,052

 

 

1,531,662

 

Property, plant and equipment, net of accumulated depreciation of

 

 

 

 

 

 

 

 

 

$408,885 and $406,375, respectively

 

165,080

 

 

166,148

 

Goodwill

 

191,616

 

 

191,616

 

Deferred income taxes

 

5,303

 

 

6,572

 

Other, net

 

100,722

 

 

102,670

 

 

 

 

 

$

2,035,773

 

$

1,998,668

 

 

 

 

 

 

 

 

 

 

Liabilities and Shareholders’ Equity

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Current installments of long-term debt and capital lease obligations

$

13,865

 

$

12,396

 

 

Accounts payable

 

343,796

 

 

326,249

 

 

Income taxes payable

 

4,118

 

 

3,534

 

 

Accrued liabilities

 

75,389

 

 

70,202

 

 

 

 

Total current liabilities

 

437,168

 

 

412,381

 

Long-term debt and capital lease obligations, less current installments

 

206,463

 

 

211,252

 

Other long-term liabilities

 

10,083

 

 

9,570

 

Shareholders’ equity:

 

 

 

 

 

 

 

Preferred stock, $0.10 par value; 5,000 shares authorized, none issued

 

 

 

 

 

Common stock, $0.10 par value; 145,000 shares authorized; issued

 

 

 

 

 

 

 

 

and outstanding – 49,710 and 49,330, respectively

 

4,971

 

 

4,933

 

 

Additional paid-in capital

 

632,863

 

 

626,306

 

 

Retained earnings

 

757,437

 

 

748,402

 

 

Accumulated other comprehensive loss

 

(13,212)

 

 

(14,176)

 

 

 

 

Total shareholders’ equity

 

1,382,059

 

 

1,365,465

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

$

2,035,773

 

$

1,998,668

See accompanying notes to condensed consolidated financial statements.

1


 

BENCHMARK ELECTRONICS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Income

(unaudited)

 

 

 

Three Months Ended

 

 

March 31,

(in thousands, except per share data)

 

2017

 

 

2016

 

 

 

 

 

 

 

Sales

$

566,501

 

$

549,225

Cost of sales

 

517,441

 

 

498,908

 

Gross profit

 

49,060

 

 

50,317

Selling, general and administrative expenses

 

32,651

 

 

28,456

Amortization of intangible assets

 

2,481

 

 

2,804

Restructuring charges and other costs

 

1,511

 

 

2,789

 

Income from operations

 

12,417

 

 

16,268

Interest expense

 

(2,225)

 

 

(2,334)

Interest income

 

1,074

 

 

264

Other expense, net

 

(81)

 

 

(223)

 

Income before income taxes

 

11,185

 

 

13,975

Income tax expense

 

1,498

 

 

2,923

 

Net income

$

9,687

 

$

11,052

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

 

Basic

$

0.20

 

$

0.22

 

Diluted

$

0.19

 

$

0.22

 

 

 

 

 

 

 

Weighted-average number of shares outstanding:

 

 

 

 

 

 

Basic

 

49,511

 

 

49,848

 

Diluted

 

50,080

 

 

50,287

See accompanying notes to condensed consolidated financial statements.

2


 

BENCHMARK ELECTRONICS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Comprehensive Income

(unaudited)

 

 

 

 

 

 

Three Months Ended

 

 

 

 

 

March 31,

(in thousands)

 

2017

 

 

2016

 

 

 

 

 

 

 

 

 

 

Net income

$

9,687

 

$

11,052

Other comprehensive loss:

 

 

 

 

 

 

Foreign currency translation adjustments

 

608

 

 

1,348

 

Unrealized gain (loss) on investments, net of tax

 

4

 

 

(6)

 

Unrealized gain (loss) on derivative, net of tax

 

365

 

 

(2,232)

 

Other

 

(13)

 

 

-

Other comprehensive loss

 

964

 

 

(890)

 

 

 

Comprehensive income

$

10,651

 

$

10,162

 

 

 

 

 

 

 

 

 

 

See accompanying notes to condensed consolidated financial statements.

3


 

BENCHMARK ELECTRONICS, INC. AND SUBSIDIARIES

Condensed Consolidated Statement of Shareholders’ Equity

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

Common Stock

 

Additional

 

 

 

 

Other

 

 

Total

 

 

 

Shares

 

Par

 

Paid-in

 

Retained

 

Comprehensive

Shareholders’

(in thousands)

 

Outstanding

 

Value

 

Capital

 

Earnings

 

 

Loss

 

 

Equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances, December 31, 2016

 

 

49,330

 

 

$  4,933

 

$  626,306

 

$  748,402

 

 

$  (14,176)

 

 

$  1,365,465

Stock-based compensation expense

 

 

-

 

 

-

 

2,160

 

-

 

 

-

 

 

2,160

Shares repurchased and retired

 

 

(31)

 

 

(3)

 

(345)

 

(652)

 

 

-

 

 

(1,000)

Stock options exercised

 

 

256

 

 

26

 

5,115

 

-

 

 

-

 

 

5,141

Vesting of restricted stock units

 

 

166

 

 

16

 

(16)

 

-

 

 

-

 

 

-

Shares withheld for taxes

 

 

(11)

 

 

(1)

 

(357)

 

-

 

 

-

 

 

(358)

Net income

 

 

-

 

 

-

 

-

 

9,687

 

 

-

 

 

9,687

Other comprehensive income

 

 

-

 

 

-

 

-

 

-

 

 

964

 

 

964

Balances, March 31, 2017

 

 

49,710

 

 

$  4,971

 

$  632,863

 

$  757,437

 

 

$  (13,212)

 

 

$  1,382,059

See accompanying notes to condensed consolidated financial statements.

4


 

BENCHMARK ELECTRONICS, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(unaudited)

 

 

 

 

 

 

Three Months Ended

 

 

 

 

 

March 31,

(in thousands)

 

2017

 

 

2016

 

 

 

 

 

 

 

 

 

 

Cash flows from operating activities:

 

 

 

 

 

 

Net income

$

9,687

 

$

11,052

 

Adjustments to reconcile net income to net cash provided by

 

 

 

 

 

 

 

operating activities:

 

 

 

 

 

 

 

 

Depreciation

 

9,320

 

 

10,621

 

 

 

Amortization

 

2,953

 

 

3,286

 

 

 

Deferred income taxes

 

1,041

 

 

633

 

 

 

Gain on the sale of property, plant and equipment

 

(197)

 

 

(93)

 

 

 

Asset impairments

 

-

 

 

121

 

 

 

Stock-based compensation expense

 

2,160

 

 

2,113

 

 

 

Excess tax benefits from stock-based compensation

 

-

 

 

(149)

 

Changes in operating assets and liabilities, net of effects from

 

 

 

 

 

 

 

business acquisition:

 

 

 

 

 

 

 

 

Accounts receivable

 

59,685

 

 

65,382

 

 

 

Inventories

 

(22,512)

 

 

22,756

 

 

 

Prepaid expenses and other assets

 

(5,329)

 

 

(5,403)

 

 

 

Accounts payable

 

16,225

 

 

(31,940)

 

 

 

Accrued liabilities

 

5,256

 

 

(1,499)

 

 

 

Income taxes

 

(384)

 

 

201

 

 

 

 

Net cash provided by operations

 

77,905

 

 

77,081

Cash flows from investing activities:

 

 

 

 

 

 

Additions to property, plant and equipment

 

(7,012)

 

 

(7,700)

 

Proceeds from the sale of property, plant and equipment

 

217

 

 

130

 

Additions to purchased software

 

(566)

 

 

(137)

 

Other

 

(108)

 

 

62

 

 

 

 

Net cash used in investing activities

 

(7,469)

 

 

(7,645)

Cash flows from financing activities:

 

 

 

 

 

 

Proceeds from stock options exercised

 

5,141

 

 

763

 

Employee taxes paid for shares withheld

 

(358)

 

 

(568)

 

Excess tax benefits from stock-based compensation

 

-

 

 

149

 

Principal payments on long-term debt and capital lease obligations

 

(3,082)

 

 

(3,078)

 

Share repurchases

 

(1,000)

 

 

(14,205)

 

Debt issuance costs

 

(434)

 

 

-

 

 

 

 

Net cash provided by (used in) financing activities

 

267

 

 

(16,939)

Effect of exchange rate changes

 

341

 

 

675

Net increase in cash and cash equivalents

 

71,044

 

 

53,172

 

Cash and cash equivalents at beginning of year

 

681,433

 

 

465,995

 

Cash and cash equivalents at end of period

$

752,477

 

$

519,167

See accompanying notes to condensed consolidated financial statements.

5


 

BENCHMARK ELECTRONICS, INC. AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(amounts in thousands, except per share data, unless otherwise noted)

(unaudited)

 

Note 1 – Basis of Presentation

Benchmark Electronics, Inc. (the Company) is a Texas corporation that provides worldwide integrated electronic manufacturing services (EMS), engineering and design services, and precision machining services. The Company provides services to original equipment manufacturers (OEMs) in the following industries: industrial controls, aerospace and defense (A&D), telecommunications, computers and related products for business enterprises, medical devices, and test and instrumentation. The Company has manufacturing operations located in the United States and Mexico (the Americas), Asia and Europe.

 

The unaudited condensed consolidated financial statements included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the SEC). The financial statements reflect all normal and recurring adjustments necessary in the opinion of management for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. The results of operations for the periods presented are not necessarily indicative of the results to be expected for the full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and notes included in the Company’s annual report on Form 10‑K for the year ended December 31, 2016 (the 2016 10-K).

 

Management has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare these financial statements in accordance with generally accepted accounting principles in the United States (U.S. GAAP). Actual results could differ from those estimates and assumptions.

 

Effective January 1, 2017, the Company adopted a new accounting standard update that simplifies several aspects of the accounting for employee share-based payment transactions, including accounting for income taxes, forfeitures, and statutory withholding requirements, as well as classification in the Condensed Consolidated Statements of Cash Flows. As required by this standard, excess tax benefits recognized on stock-based compensation expense are reflected in the accompanying Condensed Consolidated Income Statement as a component of the provision for income taxes on a prospective basis (See Note 8). As a result of including the income tax effects from excess tax benefits in income tax expense, the effects of the excess tax benefits are no longer included in the calculation of diluted shares outstanding, resulting in an increase in the number of diluted shares outstanding. The Company adopted this change in the method of calculating diluted shares outstanding on a prospective basis. Additionally, excess tax benefits or deficiencies recognized on stock-based compensation expense are classified as an operating activity in the accompanying Condensed Consolidated Statements of Cash Flows. The Company has applied this provision prospectively. Additionally, the Company is now required to present the cost of shares withheld from the employee to satisfy the employees’ income tax liability as a financing activity on the statement of cash flows rather than as an operating cash flow. The Company adopted this change retrospectively. As a result, for the three months ended March 31, 2016, net cash provided by operations increased by $568 with a corresponding offset to net cash used in financing activities. The standard also allows for the option to account for forfeitures as they occur when determining the amount of compensation cost to be recognized, rather than estimating expected forfeitures over the course of a vesting period. The Company elected to account for forfeitures as they occur. The net cumulative effect to the Company from the adoption of this accounting standard update was an increase to paid-in capital of $213 and a reduction to retained earnings of $213 as of January 1, 2017.

 

Certain reclassifications of prior period amounts have been made to conform to the current period presentation. During the quarter ended September 30, 2016, the Company concluded that it was appropriate

6  


 

to classify amounts relating to the amortization of intangible assets separately. Previously, the Company had reported these amounts under the captions “cost of sales” and “selling, general and administrative expenses”. These reclassifications had no effect on previously reported net income.

 

Note 2 – Stock-Based Compensation

The Company’s 2010 Omnibus Incentive Compensation Plan (the 2010 Plan) authorizes, the Company, upon approval of the Compensation Committee of the Board of Directors, to grant a variety of awards, including stock options, restricted shares, restricted stock units (both time-based and performance-based) and other forms of equity awards, or any combination thereof, to any director, officer, employee or consultant (including any prospective director, officer, employee or consultant) of the Company. Stock options are granted to employees with an exercise price equal to the market price of the Company’s common shares on the date of grant, generally vest over a four-year period from the date of grant and have a term of ten years. Time-based restricted stock units granted to employees generally vest over a four-year period from the date of grant, subject to the continued employment of the employee by the Company. Performance-based restricted stock units generally vest over a three-year performance cycle, which includes the year of the grant, and are based upon the Company’s achievement of specified performance metrics. Awards under the 2010 Plan to non-employee directors have been in the form of restricted stock units, which vest in equal quarterly installments over a one-year period, starting on the grant date.

 

As of March 31, 2017 , 3.5  million additional common shares were available for issuance under the Company’s 2010 Plan.

 

All share-based payments to employees, including grants of employee stock options, are recognized in the financial statements based on their grant date fair values. The total compensation cost recognized for stock-based awards was $2.2 million and $2.1 million for the three months ended March 31, 2017 and 2016, respectively. The total income tax benefit recognized in the condensed consolidated income statement for stock-based awards was $0.8 million and $0.6 million for the three months ended March 31, 2017 and 2016, respectively. Awards of restricted stock units and performance-based restricted stock units are valued at the closing market price of the Company’s common shares on the date of grant. For performance-based restricted stock units, compensation expense is based on the probability that the performance goals will be achieved, which is monitored by management throughout the requisite service period. When it becomes probable, based on the Company’s expectation of performance during the measurement period, that more or less than the previous estimate of the awarded shares will vest, an adjustment to stock-based compensation expense is recognized as a change in accounting estimate.

 

As of March 31, 2017, the unrecognized compensation cost and remaining weighted-average amortization period related to stock-based awards were as follows:

 

 

 

 

 

 

Performance-

 

 

 

 

 

 

based

 

 

 

 

Restricted

 

Restricted

 

 

Stock

 

Stock

 

Stock

(in thousands)

 

Options

 

 Units 

 

Units (1)

Unrecognized compensation cost

 

 $  1,505

 

 

 $  14,431

 

 

 $  6,090

Remaining weighted-average

 

 

 

 

 

 

 

 

  amortization period

1.4 years

 

 

2.8 years

 

 

2.2 years

 

 

 

 

 

 

 

 

 

(1) Based on the probable achievement of the performance goals identified in each award.

7  


 

The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model. No options were granted during the three months ended March 31, 2017 and 2016.

 

The total cash received by the Company as a result of stock option exercises for the three months ended March 31, 2017 and 2016 was approximately $5.1 million and $0.8 million, respectively. The actual tax benefit realized as a result of stock option exercises and the vesting of other share-based awards during the three months ended March 31, 2017 and 2016 was $2.8 million and $1.5 million, respectively. For the three months ended March 31, 2017 and 2016, the total intrinsic value of stock options exercised was $3.1 million and $0.3 million, respectively.

 

The Company awarded performance-based restricted stock units to employees during the three months ended March 31, 2017 and 2016. The number of performance-based restricted stock units that will ultimately be earned will not be determined until the end of the corresponding performance periods, and may vary from as low as zero to as high as 2.5 times the target number depending on the level of achievement of certain performance goals. The level of achievement of these goals is based upon the audited financial results of the Company for the last full calendar year within the performance period. The performance goals consist of certain levels of achievement using the following financial metrics: revenue growth, operating margin expansion, and return on invested capital. If the performance goals are not met based on the Company’s financial results, the applicable performance-based restricted stock units will not vest and will be forfeited. Shares subject to forfeited performance-based restricted stock units will be available for issuance under the 2010 Plan.

 

The following table summarizes activities relating to the Company’s stock options:

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

Weighted-

 

Average

 

 

 

 

 

 

 

Average

 

Remaining

 

Aggregate

 

 

Number of

 

 

Exercise

 

Contractual

 

Intrinsic

(in thousands, except per share data)

 

Options

 

 

Price

 

Term (Years)

 

Value

Outstanding as of December 31, 2016

 

1,197

 

 

$19.51

 

 

 

 

Exercised

 

(256)

 

 

20.07

 

 

 

 

Forfeited or expired

 

(10)

 

 

19.78

 

 

 

 

Outstanding as of March 31, 2017

 

931

 

 

$19.35

 

5.49

 

$  11,585

Exercisable as of March 31, 2017

 

771

 

 

$18.58

 

3.74

 

$  10,195

 

The aggregate intrinsic value in the table above is before income taxes and is calculated as the difference between the exercise price of the underlying options and the Company’s closing stock price as of the last business day of the period ended March 31, 2017 for options that had exercise prices that were below the closing price.

 

The following table summarizes the activities related to the Company’s time-based restricted stock units:

 

 

 

 

 

Weighted-

 

 

 

 

 

Average

 

 

Number of

 

 

Grant Date

(in thousands, except per share data)

 

Units

 

 

Fair Value

Non-vested awards outstanding as of December 31, 2016

 

525

 

 

$22.57

Granted

 

226

 

 

31.40

Vested

 

(165)

 

 

21.04

Forfeited

 

(8)

 

 

25.52

Non-vested awards outstanding as of March 31, 2017

 

578

 

 

$26.42

8  


 

The following table summarizes the activities related to the Company’s performance-based restricted stock units:

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

Average

 

 

 

Number of

 

 

Grant Date

(in thousands, except per share data)

 

 

Units

 

 

Fair Value

Non-vested units outstanding as of December 31, 2016

 

 

227

 

 

$21.43

Granted (1)

 

 

144

 

 

31.40

Forfeited or expired

 

 

(36)

 

 

17.58

Non-vested units outstanding as of March 31, 2017

 

 

335

 

 

$26.15

(1)  Represents target number of units that can vest based on the achievement of the performance goals.

 

Note 3 – Earnings Per Share

Basic earnings per share is computed using the weighted-average number of shares outstanding. Diluted earnings per share is computed using the weighted-average number of shares outstanding adjusted for the incremental shares attributed to outstanding stock equivalents. Stock equivalents include common shares issuable upon the exercise of stock options and other equity instruments, and are computed using the treasury stock method. Under the treasury stock method, the exercise price of a share, and the amount of compensation cost, if any, for future service that the Company has not yet recognized are assumed to be used to repurchase shares in the current period.

 

The following table sets forth the calculation of basic and diluted earnings per share:

 

 

 

 

Three Months Ended

 

 

 

March 31,

(in thousands, except per share data)

 

 

2017

 

 

2016

Net income

 

$

9,687

 

$

11,052

 

 

 

 

 

 

 

 

Denominator for basic earnings per share - weighted-average number of

 

 

 

 

 

 

 

common shares outstanding during the period

 

 

49,511

 

 

49,848

Incremental common shares attributable to exercise of dilutive options

 

 

361

 

 

292

Incremental common shares attributable to outstanding restricted

 

 

 

 

 

 

 

stock units

 

 

208

 

 

147

Denominator for diluted earnings per share

 

 

50,080

 

 

50,287

 

 

 

 

 

 

 

 

Basic earnings per share

 

 

$0.20

 

 

$0.22

Diluted earnings per share

 

 

$0.19

 

 

$0.22

 

Options to purchase 1.2 million common shares for the three months ended March 31, 2016 were not included in the computation of diluted earnings per share because their effect would have been anti-dilutive.

9  


 

Note 4 – Goodwill and Other Intangible Assets

Goodwill allocated to the Company’s reportable segments was as follows:

 

(in thousands)

 

Americas

 

Asia

 

Total

Goodwill as of December 31, 2016 and March 31, 2017

$

153,514

$

38,102

$

191,616

 

 

 

 

 

 

 

 

Other assets consist primarily of acquired identifiable intangible assets and capitalized purchased software costs. Acquired identifiable intangible assets as of March 31, 2017 and December 31, 2016 were as follows:

 

 

Gross

 

 

 

 

 

Net

 

 

Carrying

 

Accumulated

 

Carrying

(in thousands)

 

Amount

 

Amortization

 

Amount

Customer relationships

$

100,070

 

$

(29,485)

 

$

70,585

Purchased software costs

 

32,141

 

 

(28,777)

 

 

3,364

Technology licenses

 

26,800

 

 

(15,079)

 

 

11,721

Trade names and trademarks

 

7,800

 

 

-

 

 

7,800

Other

 

868

 

 

(243)

 

 

625

Intangible assets, March 31, 2017

$

167,679

 

$

(73,584)

 

$

94,095

 

 

 

 

 

 

 

 

 

 

 

Gross

 

 

 

 

 

Net

 

 

Carrying

 

Accumulated

 

Carrying

(in thousands)

 

Amount

 

Amortization

 

Amount

Customer relationships

$

100,053

 

$

(27,883)

 

$

72,170

Purchased software costs

 

31,582

 

 

(28,508)

 

 

3,074

Technology licenses

 

26,800

 

 

(14,189)

 

 

12,611

Trade names and trademarks

 

7,800

 

 

-

 

 

7,800

Other

 

868

 

 

(237)

 

 

631

Intangible assets, December 31, 2016

$

167,103

 

$

(70,817)

 

$

96,286

 

Customer relationships are being amortized on a straight-line basis over a period of 10 to 14 years. Capitalized purchased software costs are being amortized on a straight-line basis over the estimated useful life of the related software, which ranges from 2 to 10 years. Technology licenses are being amortized over their estimated useful lives in proportion to the economic benefits consumed. The Company’s acquired trade names and trademarks have been determined to have an indefinite life. Amortization for the three months ended March 31, 2017 and 2016 was as follows:

 

Three Months Ended

 

March 31,

(in thousands)

 

2017

 

 

2016

Amortization of intangible assets

$

2,481

 

$

2,804

Amortization of capitalized purchased software costs

 

276

 

 

293

Amortization of debt costs

 

196

 

 

189

 

$

2,953

 

$

3,286

10  


 

The estimated future amortization expense of acquired intangible assets for each of the next five years is as follows (in thousands):

 

Year ending December 31,

 

Amount

2017 (remaining nine months)

$

8,210

2018

 

9,968

2019

 

9,761

2020

 

9,196

2021

 

6,389

 

Note 5 – Borrowing Facilities

The Company has a $430 million Credit Agreement (the Credit Agreement) by and among Benchmark, JPMorgan Chase Bank, N.A. as administrative agent and collateral agent (the Administrative Agent), and the financial institutions acting as lenders thereunder from time to time . This Credit Agreement provides for a five-year $200 million revolving credit facility and a five-year $230 million term loan facility (the Term Loan), both with a maturity date of November 12, 2020.   The revolving credit facility is available for general corporate purposes, may be drawn in foreign currencies up to an amount equivalent to $20 million, and may be used for letters of credit up to $20 million. The Credit Agreement includes an accordion feature, pursuant to which total commitments under the facility may be increased by an additional $150 million, subject to the satisfaction of certain conditions.

 

The Term Loan is payable in minimum quarterly principal installments of $2.9 million in 2017, $4.3 million in 2018, $5.8 million in 2019, and $8.6 million in 2020, with the balance payable on the maturity date.

 

Interest on outstanding borrowings under the Credit Agreement accrues, at our option, at (a) the adjusted London interbank offered rate (LIBOR) plus 1.25% to 2.25%, or (b) the alternative base rate plus 0.25% to 1.25%, and is payable quarterly in arrears. The alternative base rate is equal to the highest of (i) the Administrative Agent’s prime rate, (ii) the federal funds rate plus 0.50% and (iii) the adjusted LIBOR rate plus 1.00%. The margin on the interest rates fluctuates based upon the ratio of the Company’s debt to its consolidated EBITDA. As of March 31, 2017, $161.7 million of the outstanding debt under the Credit Agreement was effectively at a fixed interest rate as a result of a $161.7 million notional interest rate swap contract discussed in Note 14. A commitment fee of 0.30% to 0.40% per annum (based on the debt to EBITDA ratio) on the unused portion of the revolving credit line is payable quarterly in arrears.

 

The Credit Agreement is generally secured by a pledge of (a) all the capital stock of the Company’s domestic subsidiaries and 65% of the capital stock of its directly owned foreign subsidiaries, (b) any indebtedness owed to Benchmark and its subsidiaries and (c) all or substantially all other personal property of Benchmark and its domestic subsidiaries (including, accounts receivable, inventory and fixed assets of Benchmark and its domestic subsidiaries), in each case, subject to customary exceptions and limitations. The Credit Agreement contains financial covenants as to debt leverage and interest coverage, and certain customary affirmative and negative covenants, including restrictions on our ability to incur additional debt and liens, pay dividends, repurchase shares, sell assets and merge or consolidate with other persons. Amounts due under the Credit Agreement may be accelerated upon specified events of default, including a failure to pay amounts due, breach of a covenant, material inaccuracy of a representation, or occurrence of bankruptcy or insolvency, subject, in some cases, to cure periods. As of March 31, 2017 and December 31, 2016, the Company was in compliance with all of these covenants and restrictions.

 

As of March 31, 2017, the Company had $215.6 million in borrowings outstanding under the Term Loan facility and $2.1 million in letters of credit outstanding under the revolving credit facility. The Company

11  


 

has $197.9 million available for future borrowings under the revolving credit facility.

 

The Company’s Thailand subsidiary has a multi-purpose credit facility with Kasikornbank Public Company Limited (the Thai Credit Facility) that provides for 350 million Thai baht working capital availability. The Thai Credit Facility is secured by land and buildings in Thailand owned by the Company’s Thailand subsidiary. Availability of funds under the Thai Credit Facility is reviewed annually and is currently accessible through October 2017. As of both March 31, 2017 and 2016, there were no working capital borrowings outstanding under the facility.

 

Note 6 – Inventories

Inventory costs are summarized as follows:

 

 

March 31,

 

December 31,

(in thousands)

 

2017

 

 

2016

Raw materials

$

261,328

 

$

233,111

Work in process

 

106,512

 

 

113,496

Finished goods

 

36,183

 

 

34,727

 

$

404,023

 

$

381,334

 

Note 7 – Accounts Receivable Sale Program

In connection with a trade accounts receivable sale program with an unaffiliated financial institution, the Company may elect to sell, at a discount, on an ongoing basis, up to a maximum of $40.0 million, of specific accounts receivable at any one time. The program was executed on March 29, 2017, is an uncommitted facility and is scheduled to expire in one year with options to automatically extend the agreement, although any party may elect to terminate the agreement upon 60 days prior notice.

 

During the three months ended March 31, 2017, the Company sold $25.0 million of accounts receivable under this program. In exchange, the Company received cash proceeds of $25.0 million, less a discount. The loss on the sale resulting from the discount during the three months ended March 31, 2017 was not material, and was recorded to other expense within the Condensed Consolidated Statements of Income.

 

Note 8 – Income Taxes

Income tax expense consists of the following:

 

Three Months Ended

 

March 31,

(in thousands)

 

2017

 

 

2016

Federal – current

$

(783)

 

$

815

Foreign – current

 

1,112

 

 

1,375

State – current

 

128

 

 

100

Deferred

 

1,041

 

 

633

 

$

1,498

 

$

2,923

 

Income tax expense differs from the amount computed by applying the U.S. federal statutory income tax rate to income before income tax primarily due to the mix of taxable income by taxing jurisdiction, the impact of tax incentives and tax holidays in foreign locations, and state income taxes (net of federal benefit). The decrease in income tax expense during 2017 is primarily the result of a new tax incentive in China and the recognition of excess tax benefits attributable to the adoption of an accounting standard effective January 1, 2017. See Note 1. Under this standard, the excess tax benefits or deficiencies resulting from the exercise or vesting of awards are included in income tax expense in the reporting period in which they occur. Therefore, the tax effect of stock option exercises and RSU vesting is not spread over the entire

12  


 

year through the use of the annual effective tax rate, but instead is recorded entirely in the period in which the tax deduction arose. Accordingly, the Company recorded the income tax benefit as a discrete item for the three months ended March 31, 2017. The Company’s effective tax rate could fluctuate significantly on a quarterly basis due to the tax effects of stock-based compensation.

 

The Company considers earnings from foreign subsidiaries to be indefinitely reinvested and, accordingly, no provision for U.S. federal and state income taxes has been made for these earnings. Upon distribution of foreign subsidiary earnings in the form of dividends or otherwise, such distributed earnings would be subject to U.S. income taxes and foreign withholding taxes, reduced by any applicable foreign tax credits. Determination of the amount of any unrecognized deferred tax liability on these undistributed earnings is not practicable.

 

The Company has been granted certain tax incentives, including tax holidays, for its subsidiaries in China, Malaysia and Thailand that will expire at various dates, unless extended or otherwise renegotiated, through 2018 in China, 2021 in Malaysia and 2028 in Thailand, and are subject to certain conditions with which the Company expects to comply. The net impact of these tax incentives was to lower income tax expense for the three months ended March 31, 2017 and 2016 by approximately $1.3 million (approximately 0.03 per diluted share) and $0.9 million (approximately $0.02 per diluted share), respectively, as follows:

 

 

Three Months Ended

 

March 31,

(in thousands)

 

2017

 

 

2016

China

$

167

 

$

-

Malaysia

 

532

 

 

367

Thailand

 

556

 

 

560

 

$

1,255

 

$

927

 

As of March 31, 2017, the total amount of the reserve for uncertain tax benefits including interest was $8.1 million. The reserve is classified as a current or long-term liability in the condensed consolidated balance sheets based on the Company’s expectation of when the items will be settled. The amount of accrued potential interest on unrecognized tax benefits included in the reserve as of March 31, 2017, was $0.1 million. There was no reserve for potential penalties. No material changes affected the reserve during the three months ended March 31, 2017.

 

The Company and its subsidiaries in Brazil, China, Ireland, Luxembourg, Malaysia, Mexico, the Netherlands, Romania, Singapore, Thailand and the United States remain open to examination by the various local taxing authorities, in total or in part, for fiscal years 2011 to 2016. A subsidiary in Thailand remains open to examination for fiscal years 2004 to 2005 for a tax audit that is still outstanding.

 

The Company is currently under examination by the U.S. Internal Revenue Service for 2014. During the course of such examinations, disputes may occur as to matters of fact or law. Also, in most tax jurisdictions, the passage of time without examination will result in the expiration of applicable statutes of limitations thereby precluding examination of the tax period(s) for which such statute of limitation has expired. The Company believes that it has adequately provided for its tax liabilities.

13  


 

Note 9 – Segment and Geographic Information

The Company currently has manufacturing facilities in the Americas, Asia and Europe to serve its customers. The Company is operated and managed geographically, and management evaluates performance and allocates the Company’s resources on a geographic basis. Intersegment sales are generally recorded at prices that approximate arm’s length transactions. Operating segments’ measure of profitability is based on income from operations. The accounting policies for the reportable operating segments are the same as for the Company taken as a whole. The Company has three reportable operating segments: Americas, Asia and Europe. Information about operating segments is as follows:

 

 

 

Three Months Ended

 

 

March 31,

(in thousands)

 

2017

 

2016

Net sales:

 

 

 

 

 

Americas

$

374,559

$

352,814

 

Asia

 

174,891

 

173,370

 

Europe

 

40,416

 

42,015

 

Elimination of intersegment sales

 

(23,365)

 

(18,974)

 

 

$

566,501

$

549,225

 

 

 

 

 

 

Depreciation and amortization:

 

 

 

 

 

Americas

$

5,505

$

5,766

 

Asia

 

3,166

 

4,120

 

Europe

 

657

 

704

 

Corporate

 

2,945

 

3,317

 

 

$

12,273

$

13,907

 

 

 

 

 

 

Income from operations:

 

 

 

 

 

Americas

$

15,196

$

18,045

 

Asia

 

12,321

 

10,892

 

Europe

 

2,381

 

2,952

 

Corporate and intersegment eliminations

 

(17,481)

 

(15,621)

 

 

$

12,417

$

16,268

 

 

 

 

 

 

Capital expenditures:

 

 

 

 

 

Americas

$

3,266

$

4,209

 

Asia

 

2,410

 

3,109

 

Europe

 

914

 

181

 

Corporate

 

988

 

338

 

 

$

7,578

$

7,837

 

 

 

 

 

 

 

 

 

March 31,

 

December 31,

 

 

 

2017

 

2016

Total assets:

 

 

 

 

 

Americas

$

906,746

$

864,388

 

Asia

 

647,653

 

634,838

 

Europe

 

400,129

 

393,443

 

Corporate and other

 

81,245

 

105,999

 

 

$

2,035,773

$

1,998,668

14  


 

Geographic net sales information reflects the destination of the product shipped. Long-lived assets

information is based upon the physical location of the asset.

 

 

Three Months Ended

 

 

March 31,

(in thousands)

 

2017

 

2016

Geographic net sales:

 

 

 

 

 

United States

$

374,399

$

384,988

 

Asia

 

95,075

 

71,462

 

Europe

 

76,077

 

64,944

 

Other foreign

 

20,950

 

27,831

 

 

$

566,501

$

549,225

 

 

 

 

 

 

 

 

 

March 31,

 

December 31,

 

 

 

2017

 

2016

Long-lived assets:

 

 

 

 

 

United States

$

164,773

$

167,367

 

Asia

 

68,874

 

67,998

 

Europe

 

8,683

 

8,415

 

Other foreign

 

22,721

 

24,290

 

 

$

265,051

$

268,070

 

Note 10 – Supplemental Cash Flow and Non-Cash Information

The following is additional information concerning supplemental disclosures of cash payments.

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

March 31,

(in thousands)

 

2017

 

 

2016

Income taxes paid, net

$

816

 

$

2,117

Interest paid

 

2,214

 

 

2,731

 

 

 

 

 

 

 

Non-cash investing activity:

 

 

 

 

 

Additions to property, plant and equipment in accounts payable

$

3,301

 

$

1,447

 

Note 11 – Contingencies

The Company is involved in various legal actions arising in the ordinary course of business. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on the Company’s consolidated financial position or results of operations.

 

The Company previously reported charges incurred in 2014 for the write-down of inventory and provisions to accounts receivable associated with the October 2014 bankruptcy filing of GT Advanced Technologies (GTAT). The Company noted then that its actual loss could differ from the amounts originally recorded. In October 2016, the Company learned that the trustee in the GTAT bankruptcy proceedings filed adversary actions against three of the Company’s subsidiaries to recover payments aggregating approximately $4.4 million, which were received by the subsidiaries during the 90 days preceding GTAT’s bankruptcy filing, on the premise that such payments were made during the preference period and therefore may be avoidable as preferential or constructively fraudulent, among other theories. These adversary actions are subject to mandatory mediation procedures by order of the bankruptcy court. The Company believes that the payments were made in the ordinary course of business, and, although the outcome cannot be predicted at this time, the Company intends to vigorously defend against the claims

15  


 

Note 12 – Impact of Recently Enacted Accounting Standards

In August 2016, the Financial Accounting Standards Board (FASB) issued a new accounting standards update, which seeks to reduce the existing diversity in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. This update is effective for fiscal years and interim periods beginning after December 15, 2017, with early adoption permitted. The Company is currently evaluating the impact that the adoption of this update will have on its consolidated financial statements.

 

In June 2016, the FASB issued a new accounting standards update, which replaces the current incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. This update is effective for annual reporting periods beginning after December 15, 2019. The Company does not expect the implementation of this update to have a material impact on its consolidated financial position, results of operations or cash flows.

 

In February 2016, the FASB issued a new accounting standards update changing the accounting for leases and including a requirement to record all leases on the consolidated balance sheets as assets and liabilities. This update is effective for fiscal years beginning after December 15, 2018. The Company will adopt this update effective January 1, 2019, which will impact its consolidated balance sheet. The Company is currently evaluating the impact this standard will have on its consolidated financial statements.

 

In May 2014, the FASB issued a new standard that will supersede most of the existing revenue recognition requirements in current U.S. GAAP. The new standard will require companies to recognize revenue in an amount reflecting the consideration to which they expect to be entitled in exchange for transferring goods or services to a customer. The new standard will also require significantly expanded disclosures, and is effective January 1, 2018. The new standard will permit the use of either the retrospective or cumulative effect transition method, with early application permitted for January 1, 2017. The Company plans to adopt the new guidance effective January 1, 2018. Under the new guidance, the Company anticipates that a majority of its sales from manufacturing activities will change to an over-time model. Under current guidance, the Company accounts for these under a point-in-time recognition model. Based on its analysis to date, the Company expects to adopt the new guidance under the retrospective approach. The Company is in the process of quantifying the potential effects the new guidance will have on its consolidated financial statements, and believes the adoption is likely to have a material impact on the timing of revenue recognition.

 

The Company has determined that no other recently issued accounting standards will have a material impact on its consolidated financial position, results of operations or cash flows, or will not apply to its operations.

 

Note 13 – Restructuring Charges

The Company has undertaken initiatives to restructure its business operations to improve utilization and realize cost savings. These initiatives have included changing the number and location of production facilities, largely to align capacity and infrastructure with current and anticipated customer demand. This alignment includes transferring programs from higher cost geographies to lower cost geographies. The process of restructuring entails moving production between facilities, reducing staff levels, realigning our business processes, reorganizing our management and other activities.

 

The Company recognized restructuring charges during 2017 and 2016 primarily related to the closure of facilities in the Americas, capacity reduction and reductions in workforce in certain facilities across various regions.

16  


 

The following table summarizes the 2017 activity in the accrued restructuring balances related to the restructuring activities initiated prior to March 31, 2017:

 

 

 

 

Balance as of

 

 

 

 

 

 

 

Foreign

 

Balance as of

 

 

 

December 31,

 

Restructuring

 

Cash

 

Exchange

 

March 31,

(in thousands)

 

 

2016

 

 

 

Charges

 

 

Payment

 

Adjustments

 

2017

2017 Restructuring:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Severance

 

$

-

 

 

$

754

 

$

(700)

 

$

-

 

$

54

 

Leased facilities and equipment

 

 

-

 

 

 

105

 

 

(105)

 

 

-

 

 

-

 

 

 

-

 

 

 

859

 

 

(805)

 

 

-

 

 

54

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2016 Restructuring:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Severance

 

 

738

 

 

 

51

 

 

(515)

 

 

-

 

 

274

 

Other exit costs

 

 

545

 

 

 

601

 

 

(529)

 

 

1

 

 

618

 

 

 

1,283

 

 

 

652

 

 

(1,044)

 

 

1

 

 

892

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

$

1,283

 

 

$

1,511

 

$

(1,849)

 

$

1

 

$

946

 

Note 14 – Fair Value

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. A three-tier fair value hierarchy of inputs is employed to determine fair value measurements.

·          Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets and liabilities.

·          Level 2 inputs are observable prices that are not quoted on active exchanges, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.

·          Level 3 inputs are unobservable inputs employed for measuring the fair value of assets or liabilities.

This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value.

 

The Company’s financial instruments include cash equivalents, accounts and other receivables, accounts payable, accrued liabilities and long-term debt and capital lease obligations. The Company believes that the carrying values of these instruments approximate fair value. As of March 31, 2017, the Company’s long-term investments and derivative instruments were recorded at fair value using Level 3 inputs. The Company uses derivative instruments to manage the variability of foreign currency obligations and interest rates. The Company does not enter into derivatives for speculative purposes.

 

The forward currency exchange contracts in place as of March 31, 2017 have not been designated as accounting hedges and, therefore, changes in fair value are recorded within the Condensed Consolidated Statements of Income.

 

The Company has an interest rate swap agreement with a notional amount of $161.7 million and $163.9 million as of March 31, 2017 and December 31, 2016, respectively, to hedge a portion of its interest rate exposure on outstanding borrowings under the Credit Agreement. Under this interest rate swap agreement, the Company receives variable rate interest rate payments based on the one-month LIBOR rate and pays fixed rate interest payments. The fixed interest rate for the contract is 1.4935%. The effect of this swap is to convert a portion of the floating rate interest expense to fixed interest rate expense. Based on the terms of the interest rate swap contract and the underlying borrowings outstanding under the Credit Agreement, the

17  


 

interest rate contract was determined to be effective, and thus qualifies and has been designated as a cash flow hedge. As such, changes in the fair value of the interest rate swap are recorded in other comprehensive income on the accompanying Condensed Consolidated Balance Sheets until earnings are affected by the variability of cash flows. The fair value of the interest rate swap was a $1.1 million asset as of March 31, 2017 and a $0.5 million asset as of December 31, 2016. During the three months ended March 31, 2017, the Company recorded unrealized gain of $0.6 million ($0.4 million net of tax) on the swap in other comprehensive income. See Note 15.

 

Note 15 Accumulated Other Comprehensive Loss

The changes in accumulated other comprehensive loss by component were as follows:

 

 

 

 

 

Foreign

 

 

 

 

Unrealized

 

 

 

 

 

 

 

 

 

currency

 

 

Derivative

 

loss on

 

 

 

 

 

 

 

 

 

translation

 

 

instruments,

 

investments,

 

 

 

 

 

(in thousands)

 

 

adjustments

 

 

net of tax

 

 

net of tax

 

 

Other

 

 

Total

Balances, December 31, 2016

 

$

(14,544)

 

$

286

 

$

(74)

 

$

156

 

$

(14,176)

 

Other comprehensive gain before reclassifications

 

 

608

 

 

365

 

 

4

 

 

(13)

 

 

964

Net current period other comprehensive gain (loss)

 

 

608

 

 

365

 

 

4

 

 

(13)

 

 

964

Balances, March 31, 2017

 

$

(13,936)

 

$

651

 

$

(70)

 

$

143

 

$

(13,212)

 

See Note 14 for further explanation of the change in derivative instruments that is recorded to Accumulated Other Comprehensive Loss .

18  


 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

This quarterly report (this Report) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act). These forward-looking statements are identified as any statement that does not relate strictly to historical or current facts and may include words such as “anticipate,” “believe,” “intend,” “plan,” “projection,” “forecast,” “strategy,” “position,” “continue,” “estimate,” “expect,” “may,” “will,” or the negative or other variations thereof. In particular, statements, whether express or implied, concerning future operating results or the ability to generate sales, income or cash flow are forward-looking statements. Undue reliance should not be placed on any forward-looking statements. Forward-looking statements are not guarantees of performance. They involve risks, uncertainties and assumptions that are beyond our ability to control or predict, including those discussed in Part I, Item 1A of the 2016 10-K and any added under   Part II, Item 1A of this Report. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes, including the future results of our operations, may vary materially from those indicated. The following discussion should be read in conjunction with the Condensed Consolidated Financial Statements and accompanying notes, and the 2016 10-K.

 

OVERVIEW

We are a worldwide provider of integrated electronics manufacturing services (EMS), engineering and design services, and precision machining services. We provide our services to original equipment manufacturers (OEMs) in the following industries: industrial controls, aerospace and defense (A&D), telecommunications, computers and related products for business enterprises, medical devices, and test and instrumentation. Our services include comprehensive and integrated design and manufacturing services and solutions—from initial product concept to volume production, including direct order fulfillment and aftermarket services. In this Report, references to Benchmark or the Company or use of the words “we”, “our” and “us” include the subsidiaries of Benchmark unless otherwise noted.

 

Our primary goal is to drive revenue growth at the right balance of mix and profitability as we continue transitioning our portfolio to the higher-value markets of A&D, Industrials, Medical and Test & Instrumentation. These higher-value markets offer greater outsourcing opportunities, longer lifecycle products and extended manufacturing contracts with customers who have greater outsourcing needs and require higher value-added and engineering-led solutions than customers in our traditional markets. We remain focused on key initiatives critical to our success, including the optimization of our global network; the implementation of our market-sector sales organization; and the expansion of our engineering solutions capabilities.

 

Our operations comprise three principal areas:

·          Manufacturing and assembly operations , which includes printed circuit board assemblies (PCBAs) and subsystem assembly, box build and systems integration. Systems integration is often building a finished assembly that includes PCBAs, complex subsystem assemblies, mechatronics, displays, optics, and other components. These final products may be configured to order and delivered directly to the end customer across all the industries we serve.

·          Precision technology manufacturing , which complements our electronic manufacturing expertise by providing further vertical integration of critical mechanical components. These capabilities include precision machining, advanced metal joining, assembly and functional testing primarily for customers in the test & instrumentation market (which includes semiconductor capital equipment) as well as the medical and aerospace markets.

·          Specialized engineering services and solutions , which includes new product concept development, design for systems, sub-systems, and components, printed circuit board layout, prototyping,

19  


 

automation and test development. We provide these services across all the industries we serve, but lead with engineering to manufacturing solutions primarily in regulated industries such as medical, complex industrials, aerospace and defense.

 

Our core strength lies in our ability to provide concept-to-production solutions in support of our customers. Our global manufacturing presence increases our ability to respond to our customers’ needs by providing accelerated time-to-market and time-to-volume production of high-quality products – especially for complex products with lower volume and higher mix in regulated markets. These capabilities enable us to build strong strategic relationships with our customers and to become an integral part of their operations.

 

Our customers often face challenges in designing supply chains, planning demand, procuring materials and managing their inventories efficiently due to fluctuations in their customer demand, product design changes, short product life cycles and component price fluctuations. We seek to employ enterprise resource planning (ERP) systems and lean manufacturing principles to manage the procurement and manufacturing processes in an efficient and cost-effective manner so that, where possible, components arrive on a just-in-time, as- and -when-needed basis. We are a significant purchaser of electronic components and other raw materials and can capitalize on the economies of scale associated with our relationships with suppliers to negotiate price discounts, obtain components and other raw materials that are in short supply, and return excess components. Our agility and expertise in supply chain management and our relationships with suppliers across the supply chain help enable us to reduce our customers’ cost of goods sold and inventory exposure.

 

We recognize revenue from the sale of manufactured products built to customer specifications and excess inventory when title and risk of ownership have passed, the price to the buyer is fixed or determinable and recoverability is reasonably assured, which generally is when the goods are shipped. Revenue from design, development and engineering services is recognized when the services are performed and collectibility is reasonably certain. Such services provided under fixed price contracts are generally accounted for using the percentage-of-completion method. We generally assume no significant obligations after shipment as we typically warrant workmanship only, accordingly, our warranty provisions are generally not significant.

 

2017 Highlights

Sales for the three months ended March 31, 2017 increased 3% to $566.5 million compared to $549.2 million for 2016. During 2017, sales to customers in our various industry sectors fluctuated from the comparable 2016 period as follows:

 

·          Industrials decreased by 14%,

·          A&D increased by 14%,

·          Computing increased by 10%,

·          Medical increased by 4%,

·          Telecommunications decreased by 13%, and

·          Test & Instrumentation increased by 43%.

 

The revenue increase was driven by strong Test & Instrumentation growth serving the semi-capital equipment market, A&D growth primarily from defense programs, and Computing strength from existing customers.

 

Our sales depend on the success of our customers, some of which operate in businesses associated with rapid technological change and consequent product obsolescence. Developments adverse to our major customers or their products, or the failure of a major customer to pay for components or services, can adversely affect us. A substantial percentage of our sales is made to a small number of customers, and the

20  


 

loss of a major customer, if not replaced, would adversely affect us. Sales to our 10 largest customers represented 44% and 43% of our sales in the three months ended March 31, 2017 and 2016 , respectively.

 

During the three months ended March 31, 2017, we incurred a $5.1 million charge for the write-down of inventory and a provision to accounts receivable associated with the insolvency of a customer. These charges increased cost of sales by $3.4 million and SG&A by $1.7 million.

 

We experience fluctuations in gross profit from period to period. Different programs contribute different gross profits depending on factors such as the types of services involved, location of production, size of the program, complexity of the product and level of material costs associated with the various products. Moreover, new programs can contribute relatively less to our gross profit in their early stages when manufacturing volumes are usually lower, resulting in inefficiencies and unabsorbed manufacturing overhead costs. In addition, a number of our new and higher-volume programs remain subject to competitive constraints that can exert downward pressure on our margins. During periods of low production volume, we generally have idle capacity and reduced gross profit.

 

We have undertaken initiatives to restructure our business operations with the intention of improving utilization and reducing costs. During the first three months of 2017, we recognized $1.5 million of restructuring charges, primarily related to reductions in workforce in certain facilities across various regions.

 

RESULTS OF OPERATIONS

The following table presents the percentage relationship that certain items in our Condensed Consolidated Statements of Income bear to sales for the periods indicated. The financial information and the discussion below should be read in conjunction with the Condensed Consolidated Financial Statements and Notes thereto in Item 1 of this Report.

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2017

 

 

2016

 

Sales

 

100.0

%

 

100.0

%

Cost of sales

 

91.3

 

 

90.8

 

 

Gross profit

 

8.7

 

 

9.2

 

Selling, general and administrative expenses

 

5.8

 

 

5.2

 

Amortization of intangible assets

 

0.4

 

 

0.5

 

Restructuring charges and other costs

 

0.3

 

 

0.5

 

 

Income from operations

 

2.2

 

 

3.0

 

Other income (expense), net

 

(0.2)

 

 

(0.4)

 

 

Income before income taxes

 

2.0

 

 

2.5

 

Income tax expense

 

0.3

 

 

0.5

 

 

Net income

 

1.7

%

 

2.0

%

21  


 

Sales

As noted above, sales increased 3% in 2017 from 2016 . The percentages of our sales by sector were as follows:

 

 

 

Three Months Ended

 

 

 

March 31,

 

Higher-Value Markets

 

2017

 

 

2016

 

Industrials

 

21

%

 

25

%

A&D

 

18

 

 

16

 

Medical

 

15

 

 

15

 

Test & instrumentation

 

14

 

 

10

 

 

 

 

68

 

 

66

 

Traditional Markets

 

 

 

 

 

 

Computing

 

18

 

 

17

 

Telecommunications

 

14

 

 

17

 

 

 

 

32

 

 

34

 

Total

 

100

%

 

100

%

 

Industrials. 2017  sales decreased 14% to $118.2 million from $138.0 million in 2016 primarily as a result of continued soft demand from our industrial customers

 

Aerospace and Defense. 2017  sales increased 14% to $103.9 million from $91.0 million in 2016 primarily due to increased demand from our defense customers

 

Medical. 2017  sales increased 4% to $86.1 million from $82.5 million in 2016. Medical revenues were adversely impacted by approximately $3 million due to the insolvency of a customer as noted above.

 

Testing & Instrumentation. 2017  sales increased 43% to $76.2 million from $53.4 million in 2016 . The increase reflected strong growth in the semi-capital equipment market.

 

Computing. 2017 sales increased 10% to $101.0 million from $91.4 million in 2016. The increase is primarily due to increased demand from our customers.

 

Telecommunications. 2017  sales decreased 13% to $81.1 million from $92.9 million in 2016. The decrease related primarily to a maturing and non-recurring program at a former top customer

 

Our international operations are subject to the risks of doing business abroad. See Part I, Item 1A of our 2016 10-K for factors pertaining to our international sales and fluctuations in the exchange rates of foreign currency and for further discussion of potential adverse effects in operating results associated with the risks of doing business abroad. During 2017 and 2016, 46% and 50%, respectively, of our sales were from international operations.

 

Gross Profit

Gross profit decreased 2% to $49.1 million for 2017 from $50.3 million in 2016. For the three months ended March 31, 2017, we incurred a $3.4 million charge for the write-down of inventory associated with the insolvency of a customer. Including the inventory charge, gross profit as a percentage of sales was 8.7% for the three months ended March 31, 2017. Excluding this inventory charge, gross profit as a percentage of sales increased to 9.3% for the three months ended March 31, 2017 from 9.2% in 2016 primarily due to

22  


 

benefits from our increased higher-value market revenue base, capacity alignment and operational excellence initiatives.

 

Selling, General and Administrative Expenses

SG&A increased 15% to $32.7 million in 2017 from $28.5 million in 2016. The increase was primarily a result of investments in our sales and marketing organization and a $1.7 million charge for a provision to accounts receivable associated with the insolvency of a customer. Including this provision to accounts receivable, SG&A, as a percentage of sales, increased to 5.8% in 2017 from 5.2% in 2016. Excluding this provision to accounts receivable, SG&A, as a percentage of sales, increased to 5.5% in 2017 from 5.2% in 2016 primarily due to the investment in our sales and marketing organization and increased variable compensation offset by savings from previous restructuring activities.

 

Amortization of Intangible Assets

Amortization of intangible assets decreased to $2.5 million in 2017 from $2.8 million in 2016 due primarily to certain customer relationship intangible assets that became fully amortized as of December 31, 2016.

 

Restructuring Charges and Other Costs

During 2017, we recognized $1.5 million of restructuring charges and other costs, primarily related to reductions in workforce in certain facilities across various regions. We expect to incur an additional $1.5 to $2.0 million in the remaining quarters of 2017 on capacity alignment efforts in the Americas. In 2016, we recognized $2.8 million of restructuring charges and other costs, primarily related to the closure of certain facilities in the Americas and costs associated a proxy contest relating to our 2016 annual meeting of shareholders. See Note 13 to the Condensed Consolidated Financial Statements in Item 1 of this Report.

 

Interest Income

Interest income increased to $1.1 million in 2017 from $0.3 million in 2016 due to investment of higher levels of available cash in interest bearing cash equivalents at higher interest rates.

 

Income Tax Expense

Income tax expense of $1.5 million represented an effective tax rate of 13.4% for 2017, compared with $2.9 million for 2016, which represented an effective tax rate of 20.9%. The decrease in the effective rate for 2017 is primarily a result of a $0.8 million discrete tax benefit for stock based compensation in 2017. Excluding this tax item, the effective tax rate would have been 20.5%.

 

We have been granted certain tax incentives, including tax holidays, for our subsidiaries in China, Malaysia and Thailand that will expire at various dates, unless extended or otherwise renegotiated, through 2018 in China, 2021 in Malaysia, and 2028 in Thailand. See Note 8 to the Condensed Consolidated Financial Statements in Item 1 of this report.

 

Net Income

We reported net income of $9.7 million, or diluted earnings per share of $0.19 for the first three months 2017, compared with net income of $11.1 million, or diluted earnings per share of $0.22 for 2016. The net decrease of $1.4 million from 2016 was due to the factors discussed above.

23  


 

LIQUIDITY AND CAPITAL RESOURCES

We have historically financed our organic growth and operations through funds generated from operations. In connection with the Secure Acquisition in 2015, we borrowed $230.0 million under the Term Loan facility to finance the purchase price of the acquisition. Cash and cash equivalents totaled $752.5 million at March 31, 2017 and $681.4 million at December 31, 2016, of which $93.0 million and $55.2 million, was available in the U.S. at March 31, 2017 and December 31, 2016, respectively. Substantially all of the amounts held outside of the U.S. are intended to be permanently reinvested in foreign operations. Under current tax laws and regulations, if cash and cash equivalents held outside the U.S. were to be distributed to the U.S. in the form of dividends or otherwise, we would be subject to additional U.S. income taxes and foreign withholding taxes, reduced by any applicable foreign tax credits.

 

Cash provided by operating activities during the first three months was $77.9 million for 2017 and consisted primarily of $9.7 million of net income adjusted for $12.3 million of depreciation and amortization, a $59.7 million decrease in accounts receivable, a $22.5 million increase in inventories and a $16.2 million increase in accounts payable over 2016. The decrease in accounts receivable was primarily driven by lower sales and the sale of $25.0 million of accounts receivable under an accounts receivable sales program implemented on March 29, 2017. Working capital was $1.1 billion at both March 31, 2017 and December 31, 2016.

 

We purchase components only after customer orders or forecasts are received, which mitigates, but does not eliminate, the risk of loss on inventories. Supplies of electronic components and other materials used in operations are subject to industry-wide shortages. In certain instances, suppliers may allocate available quantities to us. If shortages of these components and other material supplies used in operations occur, vendors may not ship the quantities we need for production, and we may be forced to delay shipments, which would increase backorders and impact cash flows.

 

Cash used in investing activities was $7.5 million for 2017 primarily due to purchases of additional property, plant and equipment totaling $7.0 million. The purchases of property, plant and equipment were primarily for machinery and equipment in the Americas and Asia.

 

Cash provided by financing activities was $0.3 million for 2017. Share repurchases totaled $1.0 million, principal payments on long-term debt totaled $3.1 million, and we received $5.1 million from the exercise of stock options.

 

Under the terms of our $430.0 million Credit Agreement, in addition to the Term Loan facility, we have a $200.0 million five-year revolving credit facility to be used for general corporate purposes with a maturity date of November 12, 2020. The Credit Agreement includes an accordion feature pursuant to which total commitments under the facility may be increased by an additional $150.0 million, subject to satisfaction of certain conditions. As of March 31, 2017 , we had $215.6 million in borrowings outstanding under the Term Loan facility and $2.1 million in letters of credit outstanding under the revolving credit facility. $197.9 million remains available for future borrowings under the revolving credit facility. See Note 5 to the Condensed Consolidated Financial Statements included in Item 1 of this Report for more information regarding the terms of the Credit Agreement.

 

Our operations, and the operations of businesses we acquire, are subject to certain foreign, federal, state and local regulatory requirements relating to environmental, waste management, health and safety matters. We believe we operate in substantial compliance with all applicable requirements and we seek to ensure that newly acquired businesses comply or will comply substantially with applicable requirements. To date, the costs of compliance and workplace and environmental remediation have not been material to us. However, material costs and liabilities may arise from these requirements or from new, modified or more

24  


 

stringent requirements in the future. In addition, our past, current and future operations, and the operations of businesses we have or may acquire, may give rise to claims of exposure by employees or the public, or to other claims or liabilities relating to environmental, waste management or health and safety concerns.

 

As of March 31, 2017, we had cash and cash equivalents totaling $752.5 million and had $197.9 million available for borrowings under the Credit Agreement. During the next 12 months, we believe our capital expenditures will approximate $45 to $55 million, principally for machinery and equipment to support our ongoing business around the globe.

 

In December 2015, our Board of Directors approved the repurchase of up to $100.0 million of our outstanding common shares. As of March 31, 2017, we had $91.8 million remaining under the repurchase program to purchase additional shares. We are under no commitment or obligation to repurchase any particular amount of common shares. Management believes that our existing cash balances and funds generated from operations will be sufficient to permit us to meet our liquidity requirements over the next 12 months. Management further believes that our ongoing cash flows from operations and any borrowings we may incur under our revolving credit facility will enable us to meet operating cash requirements in future years. If we consummated significant acquisition opportunities in the future, our capital needs would increase and could possibly result in our need to increase available borrowings under our Credit Agreement or access public or private debt and equity markets. There can be no assurance, however, that we would be successful in raising additional debt or equity on acceptable terms.

 

CONTRACTUAL OBLIGATIONS

 

We have certain contractual obligations for operating and capital leases that were summarized in a table of Contractual Obligations in our 2016 10-K . There have been no material changes to our contractual obligations, outside of the ordinary course of our business, since December 31, 2016.

 

OFF-BALANCE SHEET ARRANGEMENTS

 

As of March 31, 2017, we did not have any significant off-balance sheet arrangements. See Note 14 to the Condensed Consolidated Financial Statements.

 

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Management’s discussion and analysis is based upon our condensed consolidated financial statements, which have been prepared in accordance with U.S. GAAP. Our significant accounting policies are summarized in Note 1 to the Consolidated Financial Statements included in our 2016 10-K . See Note 12  to the Condensed Consolidated Financial Statements for a discussion of recently enacted accounting principles.

25  


 

Item 3 – Quantitative and Qualitative Disclosures About Market Risk

 

Our international sales comprise a significant portion of our net sales. We are exposed to risks associated with operating internationally, including:

 

      Foreign currency exchange risk;

      Import and export duties, taxes and regulatory changes;

      Inflationary economies or currencies; and

      Economic and political instability.

 

Additionally, some of our operations are in developing countries. Certain events, including natural disasters, can impact the infrastructure of a developing country more severely than they would impact the infrastructure of a developed country. A developing country can also take longer to recover from such events, which could lead to delays in our ability to resume full operations.

 

We transact business in various foreign countries and are subject to foreign currency fluctuation risks. We use natural hedging and forward contracts to economically hedge transactional exposure primarily associated with trade accounts receivable, other receivables and trade accounts payable that are denominated in a currency other than the functional currency of the respective operating entity. We do not use derivative financial instruments for speculative purposes. The forward contracts in place as of March 31, 2017 have not been designated as accounting hedges and, therefore, changes in fair value are recorded within our Consolidated Statements of Income.

 

Our sales are substantially denominated in U.S. dollars. Our foreign currency cash flows are generated in certain European and Asian countries and Mexico.

 

We are also exposed to market risk for changes in interest rates on our financial instruments, a portion of which relates to our invested cash balances. We do not use derivative financial instruments in our investing activities. We place cash and cash equivalents and investments with various major financial institutions. We protect our invested principal funds by limiting default risk, market risk and reinvestment risk. We mitigate default risk by generally investing in investment-grade securities.

 

We are also exposed to interest rate risk on borrowings under our Credit Agreement. As of March 31, 2017 , we had $215.6 million outstanding on the floating rate Term Loan facility, and we have an interest rate swap agreement with a notional amount of $161.7 million. Under this swap agreement, we receive variable rate interest rate payments and pay fixed rate interest payments. The effect of this swap is to convert a portion of our floating rate interest expense to fixed interest rate expense. The interest rate swap is designated as a cash flow hedge .

26  


 

Item 4 –  Controls and Procedures  

As of the end of the period covered by this Report, the Company’s management (with the participation of our Chief Executive Officer (CEO) and Chief Financial Officer (CFO)) conducted an evaluation pursuant to Rule 13a-15 under the Exchange Act, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures. Based on this evaluation, the CEO and CFO concluded that as of the end of the period covered by this Report such disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by the Company in reports it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and include controls and procedures designed to ensure that information required to be disclosed by the Company in such reports is accumulated and communicated to our management, including the Company’s CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.

 

There has been no change in our internal control over financial reporting that occurred during the last fiscal quarter covered by this Report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

Our management, including our CEO and CFO, does not expect that our disclosure controls and internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple errors or mistakes. Additionally, controls can be circumvented by individuals’ acts, by collusion of two or more people, or by management overriding the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, a control may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

27  


 

PART II—OTHER INFORMATION

 

Item 1.             Legal Proceedings

We are involved in various legal actions arising in the ordinary course of business. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on our consolidated financial position or results of operations.

 

In October 2016, we learned that the trustee in the GTAT bankruptcy proceedings filed adversary actions against three of subsidiaries in connection with the GTAT bankruptcy proceedings. Please see the description included above in Note 11 to the Notes to the Condensed Consolidated Financial Statements, which is incorporated by reference into this Item 1 of Part II.

 

Item 1A.        Risk Factors

There are no material changes to the risk factors set forth in Part I, Item 1A of our 2016 10-K

 

Item 2.              Unregistered Sales of Equity Securities and Use of Proceeds

(c)  The following table provides information for the quarter ended March 31, 2017 about the Company’s repurchases of its equity securities registered pursuant to Section 12 of the Exchange Act, at a total cost of $1.0 million:

ISSUER PURCHASES OF EQUITY SECURITIES

 

 

 

 

 

 

 

 

 

(d) Maximum

 

 

 

 

 

 

 

(c) Total

 

Number (or

 

 

 

 

 

 

 

Number of

 

Approximate

 

 

 

 

 

 

 

Shares

 

Dollar Value)

 

 

 

 

 

 

 

(or Units)

 

of Shares

 

 

 

 

 

 

 

Purchased as

 

(or Units) that

 

 

 

(a) Total

 

 

 

Part of

 

May Yet Be

 

 

 

Number of

 

 

 

Publicly

 

Purchased

 

 

 

Shares (or

 

(b) Average

 

Announced

 

Under the

 

 

 

Units)

 

Price Paid per Share

 

Plans or

 

Plans or

Period

 

Purchased (1)

 

(or Unit) (2)

 

Programs

 

Programs (3)

March 1 to 31, 2017

 

31,201

 

$32.03

 

31,201

 

$91.8 million

Total

 

31,201

 

$32.03

 

31,201

 

 

 

(1) All share repurchases were made on the open market.

(2) Average price paid per share is calculated on a settlement basis and excludes commission.

(3) In December 2015, the Board of Directors approved the repurchase of up to $100 million of the Company’s outstanding common shares. Share purchases may be made in the open market, in privately negotiated transactions or block transactions, at the discretion of the Company’s management and as market conditions warrant. Purchases are funded from available cash and may be commenced, suspended or discontinued at any time without prior notice. Shares repurchased under the program are retired.

28  


 

Item 6.           Exhibits

 

Exhibit

 

Number

                            Description of Exhibit

3.1

Restated Certificate of Formation of the Company dated May 17, 2016 (incorporated by reference to Exhibit 3.1 to the Company's report on Form 8-K filed with the SEC on May 17, 2016) (the 8-K) (Commission file number 1-10560)

3.2

Amended and Restated Bylaws of the Company dated May 17, 2016 (incorporated by reference to Exhibit 3.2 to the 8-K)

4.1

Specimen form of certificate evidencing the Common Shares (incorporated by reference to Exhibit 4.1 to the Company's quarterly report on Form 10-Q filed with the SEC on November 7, 2014) (Commission file number 1-10560)

10.1*

Amendment No. 1 to the Credit Agreement dated November 12, 2015.

10.2*

Amended form of restricted stock unit award agreement for use under the 2010 Plan.

10.3*

Amended form of performance-based restricted stock unit award agreement for use under the 2010 Plan.

31.1*

Section 302 Certification of Chief Executive Officer

31.2*

Section 302 Certification of Chief Financial Officer

32.1*

Section 1350 Certification of Chief Executive Officer

32.2*

Section 1350 Certification of Chief Financial Officer

101.INS (1)

XBRL Instance Document

101.SCH (1)

XBRL Taxonomy Extension Schema Document

101.CAL (1)

XBRL Taxonomy Extension Calculation Linkbase Document

101.LAB (1)

XBRL Taxonomy Extension Label Linkbase Document

101.PRE (1)

XBRL Taxonomy Extension Presentation Linkbase Document

101.DEF (1)

XBRL Taxonomy Extension Definition Linkbase Document

 

 

*   Filed herewith.

(1)   XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is not deemed filed for purposes of section 18 of the Exchange Act, and otherwise is not subject to liability under these sections.

  

29  


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on May 8,  2017 .  

 

 

BENCHMARK ELECTRONICS, INC.

 

 

(Registrant)

 

By: /s/ Paul J. Tufano

 

Paul J. Tufano

 

President and Chief Executive Officer

 

(Principal Executive Officer)

 

 

 

 

 

By: /s/ Donald F. Adam

 

Donald F. Adam

 

Chief Financial Officer

 

(Principal Financial Officer)

  

30  


 

EXHIBIT INDEX

  

 

Exhibit

 

Number

                            Description of Exhibit

 

 

3.1

Restated Certificate of Formation of the Company dated May 17, 2016 (incorporated by reference to Exhibit 3.1 to the Company's report on Form 8-K filed with the SEC on May 17, 2016) (the 8-K) (Commission file number 1-10560)

3.2

Amended and Restated Bylaws of the Company dated May 17, 2016 (incorporated by reference to Exhibit 3.2 to the 8-K)

4.1

Specimen form of certificate evidencing the Common Shares (incorporated by reference to Exhibit 4.1 to the Company's quarterly report on Form 10-Q filed with the SEC on November 7, 2014) (Commission file number 1-10560)

10.1*

Amendment No. 1 to the Credit Agreement dated November 12, 2015.

10.2*

Amended form of restricted stock unit award agreement for use under the 2010 Plan.

10.3*

Amended form of performance-based restricted stock unit award agreement for use under the 2010 Plan.

31.1*

Section 302 Certification of Chief Executive Officer

31.2*

Section 302 Certification of Chief Financial Officer

32.1*

Section 1350 Certification of Chief Executive Officer

32.2*

Section 1350 Certification of Chief Financial Officer

101.INS(1)

XBRL Instance Document

101.SCH(1)

XBRL Taxonomy Extension Schema Document

101.CAL(1)

XBRL Taxonomy Extension Calculation Linkbase Document

101.LAB(1)

XBRL Taxonomy Extension Label Linkbase Document

101.PRE(1)

XBRL Taxonomy Extension Presentation Linkbase Document

101.DEF(1)

XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

*   Filed herewith.

(1)   XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is not deemed filed for purposes of section 18 of the Exchange Act, and otherwise is not subject to liability under these sections.

31  


 

 

 

EXHIBIT 10.1

 

AMENDMENT NO. 1 , dated as of March 8, 2017 (this “ Amendment ”).  Reference is made to the Credit Agreement dated as of November 12, 2015, among Benchmark Electronics, Inc., a Delaware corporation (the “ Company ”), the Borrowing Subsidiaries party thereto, the several banks and other financial institutions or entities from time to time parties to the Credit Agreement, as lenders (the “ Lenders ”),  JPMORGAN CHASE BANK, N.A., as Administrative Agent (in such capacity, the “ Administrative Agent ”) and Collateral Agent and the various other parties thereto (as amended, restated, modified and supplemented from time to time prior to the date hereof, the “ Credit Agreement ”, and the Credit Agreement, as amended by this Amendment, the “ Amended Credit Agreement ”).  Capitalized terms used and not otherwise defined herein shall have the meanings assigned to such terms in the Amended Credit Agreement.

WHEREAS, the Company has requested that the Credit Agreement be amended as set forth in this Amendment;

WHEREAS, pursuant to Section 9.02 of the Credit Agreement, the consent of the Company and the Required Lenders on the Amendment No. 1 Effective Date (as defined below) is required to effect this Amendment and the amendments to the Credit Agreement set forth herein; and

WHEREAS, the Administrative Agent, the Company and the Lenders party hereto constituting the Required Lenders are willing to enter into this Amendment on the terms and conditions set forth herein.

NOW, THEREFORE, the parties hereto agree as follows:

Section 1.  Amendments to the Credit Agreement .  The Credit Agreement is, effective as of the Amendment No. 1 Effective Date (as defined below), hereby amended as follows:

(a)  Section 1.01 of the Credit Agreement is hereby amended by adding the following definitions in alphabetical order:

Amendment No. 1 ” means Amendment No. 1 to this Agreement, dated as of March 8, 2017 among the Company, the Guarantors, the Administrative Agent and the Lenders party thereto.

Amendment No. 1 Effective Date ” has the meaning assigned to such term in Amendment No. 1.

Bail-In Action ” means the exercise of any Write-Down and Conversion Powers by the applicable EEA Resolution Authority in respect of any liability of an EEA Financial Institution.

1


 

Bail-In Legislation ” means, with respect to any EEA Member Country implementing Article 55 of Directive 2014/59/EU of the European Parliament and of the Council of the European Union, the implementing law for such EEA Member Country from time to time which is described in the EU Bail-In Legislation Schedule.

EEA Financial Institution ” means (a) any credit institution or investment firm established in any EEA Member Country which is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country which is a parent of an institution described in clause (a) of this definition, or (c) any financial institution established in an EEA Member Country which is a subsidiary of an institution described in clauses (a) or (b) of this definition and is subject to consolidated supervision with its parent.

EEA Member Country ” means any of the member states of the European Union, Iceland, Liechtenstein, and Norway.

EEA Resolution Authority ” means any public administrative authority or any person entrusted with public administrative authority of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution.

EU Bail-In Legislation Schedule ” means the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor person), as in effect from time to time.

Outstanding Receivables Transaction Amount ” means, at any time of determination, the excess of (i) the face amount of all Receivables disposed of pursuant to Section 6.05(e) prior to such time of determination minus  (ii) any amount included in clause (i) above that is attributable to Receivables with a stated due date prior to such time of determination.

Permitted Receivables Transaction ” means a Receivables Transaction, provided that (x) the financing terms, covenants, termination events and other provisions thereof, including any Standard Receivables Undertakings, shall be market terms (as determined in good faith by the Company) and (y) the aggregate Outstanding Receivables Transaction Amount at any time in respect of all Receivables Transactions does not exceed $40,000,000.

Receivables ” means any "account" as defined under the UCC including without limitation, any receivable, account receivable, right to payment of a monetary obligation, indebtedness, contract right, chose in action, and proceeds thereof, wherever located, arising out of the sale, lease, license or assignment of any products or any other goods or services that are the subject of any contracts pursuant to which goods are sold or services are rendered by the Company and that give rise to any Receivables by the Company or any Restricted Subsidiary (“ Goods ” or Services ”, respectively); all related invoices, sales orders, bills of

2


 

lading, and other contractual rights and supporting obligations relating thereto (“ Invoices ”); all rights to payment of any interest, finance, returned check or late charges, if any; all indebtedness and other obligations owed to the Company or any Restricted Subsidiary as a result of the sale of such Goods or Services pursuant to the Invoices; any and all returned, reclaimed, and repossessed Goods sold or financed pursuant thereto; all rights as to any Goods or other property, contracts of indemnity, letters of credit, guaranties or sureties, pledges, hypothecations, mortgages, chattel mortgages, security agreements, deeds of trust, proceeds of insurance (including credit insurance on such Receivables), and other collateral, liens or proceeds thereof at any time constituting supporting obligations for such Receivables; any proceeds of the foregoing; and any and all other rights, remedies, benefits and interests, both legal and equitable, to which the Company or any Restricted Subsidiary may be entitled in respect of any of the foregoing, including, but not limited to, any rights, remedies, benefits, and interests set forth in the UCC with respect to "accounts", "payment intangibles" or "supporting obligations."

Receivables Related Rights ” means, in relation to any Receivable that is the subject of a Receivables Transaction, (i) any rights under or relating to the contract governing such Receivable to the extent necessary to enforce collection of such Receivable, (ii) all security interests or Liens and property subject thereto from time to time purporting to secure payment of such Receivable, whether pursuant to the contract governing such Receivable or otherwise, (iii) all guarantees, insurance (but only to the extent such insurance relates solely to Receivables that are of the same type as the Receivables subject of the Receivables Transaction) and other agreements or arrangements of whatever character from time to time supporting or securing payment of such Receivable whether pursuant to the contract governing such Receivable or otherwise and (iv) other assets relating to such Receivable which are customarily transferred in connection with sales or factoring of Receivables.

Receivables Transaction ” means, with respect to Company and/or any of the Restricted Subsidiaries, any transaction or series of transactions of sales or factoring involving Receivables and Receivables Related Rights pursuant to which Company or any Restricted Subsidiary may sell, convey or otherwise transfer to any other Person any Receivables (whether now existing or arising in the future) and Receivables Related Rights of Company or any Restricted Subsidiary.

Standard Receivables Undertakings ” means representations, warranties, covenants and indemnities entered into by Company or any Subsidiary of Company that Company has determined in good faith to be customary in a Permitted Receivables Transaction.

Write-Down and Conversion Powers ” means, with respect to any EEA Resolution Authority, the write-down and conversion powers of such EEA Resolution Authority from time to time under the Bail-In Legislation for the

3


 

applicable EEA Member Country, which write-down and conversion powers are described in the EU Bail-In Legislation Schedule.

(b)  Section 1.01 of the Credit Agreement is hereby a m ended by amending and restating the definition of “Defaulting Lender” as follows:

Defaulting Lender ” means, subject to Section 2.22(b) , any Lender that (a) has failed to (i) fund all or any portion of its Loans within two Business Days of the date such Loans were required to be funded by it hereunder unless such Lender notifies the Administrative Agent and the Company in writing that such failure is the result of such Lender’s determination that one or more conditions precedent to funding (each of which conditions precedent, together with any applicable default, shall be specifically identified in such writing) has not been satisfied, or (ii) pay to the Administrative Agent, any Issuing Lender or any other Lender any other amount required to be paid by it hereunder (including in respect of its participations in Letters of Credit) within two Business Days of the date when due, (b) has notified the Company, the Administrative Agent or any Issuing Lender in writing that it does not intend to comply with its funding obligations hereunder or has made a public statement to that effect (unless such writing or public statement relates to such Lender’s obligation to fund a Loan hereunder and states that such position is based on such Lender’s determination that a condition precedent to funding (which condition precedent, together with any applicable default, shall be specifically identified in such writing or public statement) cannot be satisfied, (c) has failed, within three Business Days after written request by the Administrative Agent or the Company, to confirm in writing that it will comply with its prospective funding obligations hereunder ( provided  that such Lender shall cease to be a Defaulting Lender pursuant to this clause (c) upon receipt of such written confirmation by the Administrative Agent and the Company), or (d) has, or has a direct or indirect parent company that has, (i) become the subject of a proceeding under any Debtor Relief Law, (ii) had appointed for it a receiver, custodian, conservator, trustee, administrator, assignee for the benefit of creditors or similar Person charged with reorganization or liquidation of its business or assets, including the Federal Deposit Insurance Corporation or any other state or federal regulatory authority acting in such capacity or, in the good faith determination of the Administrative Agent, has taken any action in furtherance of, or indicating its consent to, approval of, or acquiescence in, any such proceeding or appointment or (iii) become the subject of a Bail-In Action; provided  that a Lender shall not be a Defaulting Lender solely by virtue of (A) an Undisclosed Administration or (B) the ownership or acquisition of any equity interest in that Lender or any direct or indirect parent company thereof by a Governmental Authority so long as such ownership interest does not result in or provide such Lender with immunity from the jurisdiction of the courts within the United States or from the enforcement of judgments or writs of attachment on its assets or permit such Lender (or such Governmental Authority) to reject, repudiate, disavow or disaffirm any contracts or agreements made by such Person.

4


 

(c)  Section 2.22(a)(iv) of the Credit Agreement is hereby amended by amending and restating the second sentence thereof as follows:

“Subject to Section 9.18 , no reallocation hereunder shall constitute a waiver or release of any claim of any party hereunder against a Defaulting Lender arising from that Lender having become a Defaulting Lender, including any claim of a Non-Defaulting Lender as a result of such Non-Defaulting Lender’s increased exposure following such reallocation.”

(d)  Section 6.01(m) of the Credit Agreement is hereby amended by deleting “and” at the end of such section.

(e)  Section 6.01(n) of the Credit Agreement is hereby amended by deleting “.” at the end of such section and replacing such text with the following: “; and”.

(f)  Section 6.01 of the Credit Agreement is hereby amended by adding the following new Section 6.01(o):

“Indebtedness owing in connection with a Permitted Receivables Transaction in the event that any purchase of Receivables thereunder is not characterized as a “true sale.”

(g)  Section 6.02(m) of the Credit Agreement is hereby amended by deleting “and” at the end of such section.

(h)  Section 6.02(n) of the Credit Agreement is hereby amended by deleting “.” at the end of such section and replacing such text with the following: “; and”.

(i)  Section 6.02 of the Credit Agreement is hereby amended by adding the following new Section 6.02(o):

“Liens (x) on deposit accounts established for the purpose of receiving the proceeds of Receivables sold or transferred in connection with a Permitted Receivables Transaction; provided  that any amounts deposited into such accounts that do not represent (i) such proceeds or (ii) amounts deposited into such accounts to establish or maintain a minimum balance shall be transferred out of such accounts by or at the direction of the Company as soon as reasonably practicable but in no event more than 15 days from the date of their deposit into such accounts; and (y) on Receivables and Receivables Related Rights subject of a Permitted Receivables Transaction.”

(j)  Section 6.05(c) of the Credit Agreement is hereby amended by deleting “and” at the end of such section.

(k)  Section 6.05(d) of the Credit Agreement is hereby amended by deleting “.” at the end of such section and replacing such text with the following: “; and”.

5


 

(l)  Section 6.05 of the Credit Agreement is hereby amended by adding the following new Section 6.05(e):

“sales, transfers and dispositions of Receivables and Receivables Related Rights pursuant to a Permitted Receivables Transaction.”

(m)  Section 6.13 of the Credit Agreement is hereby amended by deleting “.” at the end of such section and replacing such text with the following:

“, in each case, except as permitted pursuant to Section 6.05(e).”.

(f)  Article IX of the Credit Agreement is hereby amended by adding the following new Section 9.18:

“Section 9.18  Acknowledgement and Consent to Bail-In of EEA Financial Institutions .  Notwithstanding anything to the contrary in any Loan Document or in any other agreement, arrangement or understanding among any such parties, each party hereto acknowledges that any liability of any EEA Financial Institution arising under any Loan Document, to the extent such liability is unsecured, may be subject to the write-down and conversion powers of an EEA Resolution Authority and agrees and consents to, and acknowledges and agrees to be bound by:

(a)  the application of any Write-Down and Conversion Powers by an EEA Resolution Authority to any such liabilities arising hereunder which may be payable to it by any party hereto that is an EEA Financial Institution; and

(b)  the effects of any Bail-In Action on any such liability, including, if applicable:

(i)                  a reduction in full or in part or cancellation of any such liability;

(ii)                a conversion of all, or a portion of, such liability into shares or other instruments of ownership in such EEA Financial Institution, its parent undertaking, or a bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect to any such liability under this Agreement or any other Loan Document; or

(iii)              the variation of the terms of such liability in connection with the exercise of the write-down and conversion powers of any EEA Resolution Authority.”

Section 2.  Representations and Warranties .  To induce the Administrative Agent and the Lenders to enter into this Amendment, the Company represents and warrants that as of the Amendment No. 1 Effective Date:

6


 

(a)  Organization; Powers .  The Company is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization, has all requisite power and authority to conduct its business as it is currently being conducted and is qualified and/or licensed in all jurisdictions where it is required to be so qualified or licensed to operate its business, except where the failure to so qualify or be in good standing, individually or in the aggregate, could not reasonably be expected to have a Material Adverse Effect.

(b)  Authorization; Enforceability .  This Amendment has been duly authorized by all necessary corporate action.  This Amendment has been duly executed and delivered by the Company.  This Amendment constitutes a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors’ rights or remedies generally and subject to general principles of equity, regardless of whether considered in a proceeding in equity or at law.

Section 3.  Effectiveness .  This Amendment shall become effective on the date (the “ Amendment No. 1 Effective Date ”) that the following conditions have been satisfied:

(a)  Consents . The Administrative Agent shall have received counterparts of this Amendment executed by each Loan Party, the Required Lenders and the Administrative Agent.

(b)  Expenses .  The Administrative Agent shall have received all fees required to be paid, and all expenses required to be paid or reimbursed under Section 9.03(a) of the Credit Agreement for which invoices have been presented a reasonable period of time prior to the Amendment No. 1 Effective Date, in each case on or before the Amendment No. 1 Effective Date.

(c)  Consent Fees .  The Company shall have paid to the Administrative Agent, for the account of each Lender that delivers a signature page to this Amendment, an amendment fee in an amount equal to 0.05% of the aggregate amount of such Lender’s commitments under the Initial Term A Facility and Revolving Facility as of the Amendment No. 1 Effective Date.

(d)  Officer’s Certificate . The Administrative Agent shall have received a certificate, dated the Amendment No. 1 Effective Date and signed by a Financial Officer or any other executive officer of the Company confirming that (a) after giving effect to this Amendment, no Default or Event of Default has occurred and is continuing and (b) after giving effect to this Amendment, the representations and warranties of each Loan Party set forth in the Credit Agreement and the other Loan Documents are true and correct in all material respects as of the date hereof (except to the extent that such representations and warranties specifically refer to an earlier date, in which case they were true and correct as of such earlier date).

Section 4.  Reaffirmation .  Each Loan Party hereby acknowledges its receipt of a copy of this Amendment and the Credit Agreement and its review of the terms and conditions hereof and thereof and consents to the terms and conditions of this Amendment and the Amended Credit Agreement and the transactions contemplated hereby and thereby, including the extension of credit to the Company in the form of the Loans made and Letters of Credit issued thereunder.  Each Guarantor hereby (a) affirms and confirms its guarantees and other

7


 

commitments under the Guarantee Agreement, and (b) agrees that the Guarantee Agreement is in full force and effect and shall accrue to the benefit of the Secured Parties to secure the Obligations after giving effect to this Amendment. Each Loan Party hereby (a) affirms and confirms its pledges, grants and other commitments under the Security Documents and the Liens granted by it pursuant to the Security Documents, and (b) agrees that the Security Documents and the Liens granted by it pursuant to the Security Documents are each in full force and effect after giving effect to this Amendment and shall accrue to the benefit of the Secured Parties to secure the Obligations after giving effect to this Amendment. This Amendment is not intended to constitute a novation of the Credit Agreement or any of the other Loan Documents as in effect prior to the Amendment No. 1 Effective Date.

Section 5.  Counterparts .  This Amendment may be executed in any number of counterparts and by different parties hereto on separate counterparts, each of which when so executed and delivered shall be deemed to be an original, but all of which when taken together shall constitute a single instrument.  Delivery of an executed counterpart of a signature page of this Amendment by facsimile or any other electronic transmission shall be effective as delivery of a manually executed counterpart hereof.

Section 6.  Applicable Law; Waiver of Jury Trial; Jurisdiction; Consent to Service of Process .  The provisions set forth in Sections 9.09 and 9.10 of the Credit Agreement are hereby incorporated mutatis mutandis with all references to the “Agreement” therein being deemed references to this Amendment.

Section 7.  Headings .  The headings of this Amendment are for purposes of reference only and shall not limit or otherwise affect the meaning hereof.

Section 8.  Effect of Amendment .  Except as expressly set forth herein, (i) this Amendment shall not by implication or otherwise limit, impair, constitute a waiver of or otherwise affect the rights and remedies of the Lenders, the Administrative Agent or the Collateral Agent, in each case under the Credit Agreement or any other Loan Document, and (ii) shall not alter, modify, amend or in any way affect any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or any other provision of either such agreement or any other Loan Document.  This Amendment shall constitute a Loan Document for purposes of the Credit Agreement and from and after the Amendment No. 1 Effective Date, all references to the Credit Agreement in any Loan Document and all references in the Credit Agreement to “this Agreement”, “hereunder”, “hereof” or words of like import referring to the Credit Agreement, shall, unless expressly provided otherwise, refer to the Amended Credit Agreement.  The Company hereby consents to this Amendment and confirms that all obligations of the Company under the Loan Documents to which it is a party shall continue to apply to the Amended Credit Agreement.

[Signature pages follow]

8


 

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed by their respective authorized officers as of the day and year first above written.

BENCHMARK ELECTRONICS, INC.

By:      /s/ Donald Adam
       Name: 
Donald Adam
       Title:   
Chief Financial Officer

[Signature Page to Amendment No. 1]

 


 

JP MORGAN  CHASE BANK, N.A.,
as Administrative Agent

 

By:   /s/ Justin Burton
    Name:
Justin Burton
    Title:
Vice President

[Signature Page to Amendment No. 1]

 


 

JPMORGAN CHASE BANK, N.A.,
as Lender

 

By:   /s/ Justin Burton
    Name:
Justin Burton
    Title:
Vice President

 

[Signature Page to Amendment No. 1]

 


 

Bank of America, N.A.,
as Lender

 

By:   /s/ Juan Trejo
    Name:
Juan Trejo
    Title:
Vice President

 

[Signature Page to Amendment No. 1]

 


 

Branch Banking & Trust Company,
as Lender

 

By:   /s/ Matt McCain
    Name:
Matt McCain
    Title:
Senior Vice President

 

[Signature Page to Amendment No. 1]

 


 

COMPASS BANK d/b/a BBVA Compass,
as Lender

 

By:   /s/ Raj Nambiar
    Name:
Raj Nambiar
    Title:
Sr. Vice President

 

[Signature Page to Amendment No. 1]

 


 

Wells Fargo Bank, N.A.,
as Lender

 

By:   /s/ Warren R. Ross
    Name:
Warren R. Ross
    Title:
Senior Vice President

 

[Signature Page to Amendment No. 1]

 


 

ZB, N.A.dba Amegy Bank,
as Lender

 

By:   /s/ Megan Dilger
    Name:
Megan Dilger
    Title:
Assistant Vice President

 

[Signature Page to Amendment No. 1]

 


 

ING Bank N.V., Dublin Branch
as Lender

 

By:   /s/ Padraig Matthews
    Name:
Padraig Matthews
    Title:
Vice President

 

By:   /s/ San Hassett
    Name:
Sean Hassett
    Title:
Director 

 

[Signature Page to Amendment No. 1]

 


 

HSBC Bank USA, N.A.
as Lender

 

By:   /s/ Michael Bustios
    Name:
Michael Bustios
    Title:
Vice President, 20556

 

[Signature Page to Amendment No. 1]

 


 

BOKF, NA dba Bank of Texas
as Lender

 

By:   /s/ Marian Livingston
    Name:
Marian Livingston
    Title:
SVP 

 

[Signature Page to Amendment No. 1]

 


 

 

 

Exhibit 10.2

 

FORM OF RESTRICTED STOCK UNIT AWARD AGREEMENT

Restricted Stock Unit Award Agreement under the Benchmark Electronics, Inc. 2010 Omnibus Incentive Compensation Plan dated as of [___], between Benchmark Electronics, Inc. (the “ Company ”), a Texas corporation, and [NAME].

This Restricted Stock Unit Award Agreement (this “ Award Agreement ”) sets forth the terms and conditions of an award (the “ Award ”) of [____] restricted stock units that are subject to the terms and conditions specified herein (“ RSUs ”) and that are being granted to you on the date hereof under the Benchmark Electronics, Inc. 2010 Omnibus Incentive Compensation Plan (the “ Plan ”).  Each RSU subject to this Award constitutes an unfunded and unsecured promise of the Company to deliver (or cause to be delivered) to you, subject to the terms of this Award Agreement, a share of the Company’s common stock, $0.10 par value (a “ Share ”), as set forth in Section 3 of this Award Agreement.

THIS AWARD IS SUBJECT TO ALL TERMS AND CONDITIONS OF THE PLAN AND THIS AWARD AGREEMENT, INCLUDING THE DISPUTE RESOLUTION PROVISIONS SET FORTH IN SECTION 10 OF THIS AWARD AGREEMENT.  BY SIGNING YOUR NAME BELOW, YOU SHALL HAVE CONFIRMED YOUR ACCEPTANCE OF THE TERMS AND CONDITIONS OF THIS AWARD AGREEMENT.

SECTION 1.  The Plan.  This Award is made pursuant to the Plan, all the terms of which are hereby incorporated in this Award Agreement.  In the event of any conflict between the terms of the Plan and the terms of this Award Agreement, the terms of the Plan shall govern.  In the event of any conflict between the terms of this Award Agreement and the terms of any individual employment agreement between you and the Company or any of its Subsidiaries (an “ Employment Agreement ”), the terms of your Employment Agreement shall govern.

SECTION 2.  Definitions.    Capitalized terms used in this Award Agreement that are not defined in this Award Agreement have the meanings as used or defined in the Plan.  As used in this Award Agreement, the following terms have the meanings set forth below:

(a)  Business Day ” means a day that is not a Saturday, a Sunday or a day on which banking institutions are legally permitted to be closed in the City of New York.

(b)  Cause ” means the occurrence of any one of the following:

(i)  your gross negligence in the performance of your duties with the Company, which gross negligence results in a material adverse effect on the Company, provided that no such gross negligence shall constitute “Cause” if it

1


 

 

relates to an action taken or omitted by you in the good faith, reasonable belief that such action or omission was in or not opposed to the best interests of the Company;

(ii)  your habitual neglect or disregard of your duties with the Company that is materially and demonstrably injurious to the Company, after written notice from the Company stating the duties you have failed to perform;

(iii)  your engaging in conduct or misconduct that materially harms the reputation or financial position of the Company;

(iv)  your obstruction, impedance or failure to materially cooperate with an investigation authorized by the Board, a self-regulatory organization empowered with self-regulatory responsibilities under Federal or state laws, or a governmental department or agency; or

(v)  your conviction of a felony, provided that no such conviction will constitute “Cause” if it relates to an action taken or omitted by you in the good faith, reasonable belief that such action or omission was in or not opposed to the best interests of the Company.

(c)  Good Reason ” means the occurrence of any one of the following:

(i)  a material diminution of your duties or responsibilities;

(ii)  a greater than 10% reduction in your base salary, annual bonus opportunity or long-term incentive compensation opportunity; or

(iii)  a material breach by the Company of any provision of your Employment Agreement or any other agreement between you and the Company.

A termination of your employment by you for Good Reason shall be effectuated by giving the Company written notice (“ Notice of Termination for Good Reason ”), not later than 90 days following the date of the occurrence of the circumstance that constitutes Good Reason, setting forth in reasonable detail the specific conduct of the Company or any of its Subsidiaries that constitutes Good Reason and the specific provisions of this Award Agreement, your Employment Agreement or any other agreement between you and the Company on which you relied.  The Company shall be entitled, during the 30-day period following receipt of a Notice of Termination for Good Reason, to cure the circumstances that gave rise to Good Reason, provided that the Company shall be entitled to waive its right to cure or reduce the cure period by delivery of written notice to that effect to you (such 30-day or shorter period, the “ Cure Period ”).  If, during the Cure Period, such circumstance is remedied, you shall not be permitted to terminate your employment for Good Reason as a result of such circumstance.  If, at the end of the Cure Period, the circumstance that constitutes Good Reason has not been remedied, you shall be entitled to terminate your employment for Good Reason during the 90-day period that follows the end of the Cure Period (the “ Termination Period ”).  If you do not terminate

2


 

 

your employment during the Termination Period, you shall not be permitted to terminate your employment for Good Reason as a result of such circumstance.

(d)  Vesting Date ” means each date on which your rights with respect to all or a portion of the RSUs subject to this Award Agreement may become fully vested, as provided in Section 3(a) or 3(b) of this Award Agreement.

SECTION 3.  Vesting and Delivery.  (a)  Regularly Scheduled Vesting.   On each Vesting Date set forth below, your rights with respect to the number of RSUs that corresponds to such Vesting Date, as specified in the chart below, shall become vested, provided that you must be employed by the Company or one of its Subsidiaries on the relevant Vesting Date, except as otherwise determined by the Committee in its sole discretion or as otherwise provided in your Employment Agreement.

Scheduled Vesting Date

Incremental
Percentage Vested

Incremental Number of Restricted Stock Units Vested

«Vesting_Date_1»

[   ]%

 

«Vesting_Date_2»

[   ]%

 

«Vesting_Date_3»

[   ]%

 

«Vesting_Date_4»

[   ]%

 

 

(b)  Vesting following a Change of Control.   If, during the two-year period immediately following a Change of Control, your employment is terminated by the Company or any of its Subsidiaries without Cause or you terminate your employment for Good Reason, then the date of such termination shall be deemed to be the Vesting Date of any then outstanding RSUs.

(c)  Delivery of Shares.   On each Vesting Date, the Company shall deliver to you one Share for each RSU that is scheduled to vest on such date in accordance with the terms of this Award Agreement.

SECTION 4.  Forfeiture of RSUs.   Unless the Committee determines otherwise, and except as otherwise provided in your Employment Agreement or Section 3(b) of this Award Agreement, if your rights with respect to any RSUs awarded to you pursuant to this Award Agreement have not become vested prior to the date on which your employment with the Company and its Subsidiaries terminates, your rights with respect to such RSUs shall immediately terminate, and you shall be entitled to no further payments or benefits with respect thereto.

SECTION 5.  Voting Rights; Dividend Equivalents.  Prior to the date on which Shares are delivered to you in settlement of the RSUs pursuant to this Award Agreement, you shall not be entitled to exercise any voting rights with respect to the

3


 

 

Shares underlying such RSUs and shall not be entitled to receive dividends or other distributions with respect to such Shares.

SECTION 6.  Non-Transferability of RSUs.  Unless otherwise provided by the Committee in its discretion, RSUs may not be sold, assigned, alienated, transferred, pledged, attached or otherwise encumbered except as provided in Section 9(a) of the Plan.  Any purported sale, assignment, alienation, transfer, pledge, attachment or other encumbrance of an RSU in violation of the provisions of this Section 6 and Section 9(a) of the Plan shall be void.

SECTION 7.  Withholding, Consents and Legends.   (a)  Withholding.  The delivery of Shares pursuant to Section 3 of this Agreement is conditioned on satisfaction of any applicable withholding taxes in accordance with Section 9(d) of the Plan.  In the event that there is withholding tax liability in connection with the settlement of RSUs, you may satisfy, in whole or in part, any withholding tax liability by having the Company withhold from the Shares you would be entitled to receive upon settlement of the RSUs a number of Shares having a Fair Market Value (which shall either have the meaning set forth in the Plan or shall have such other meaning as determined by the Company in accordance with applicable withholding requirements) equal to such withholding tax liability; provided, however, that if you are an officer subject to Section 16 of the Exchange Act, such withholding tax liability shall be satisfied by the Company withholding such number of Shares from the Shares you would be entitled to receive upon settlement of the RSUs, without any election on your part.

(b)  Consents; Compliance with Law.   Your rights in respect of the RSUs are conditioned on the receipt to the full satisfaction of the Committee of any required consents that the Committee may determine to be necessary or advisable (including your consenting to the Company’s supplying to any third-party recordkeeper of the Plan such personal information as the Committee deems advisable to administer the Plan) and, in accordance with Section 9(l) of the Plan, subject to the Committee’s determination that the issuance of Shares pursuant to this Award Agreement is compliant with applicable law.

(c)  Legends.    The Company may affix to certificates for Shares issued pursuant to this Award Agreement any legend that the Committee determines to be necessary or advisable (including to reflect any restrictions to which you may be subject under any applicable securities laws).  The Company may advise the transfer agent to place a stop order against any legended Shares.

SECTION 8.  Successors and Assigns of the Company.  The terms and conditions of this Award Agreement shall be binding upon and shall inure to the benefit of the Company and its successors and assigns.

SECTION 9.  Committee Discretion.   Subject to the terms of this Award Agreement and your Employment Agreement, the Committee shall have discretion with respect to any actions to be taken or determinations to be made in connection with this Award Agreement, and its determinations shall be final, binding and conclusive.

 

4


 

 

SECTION 10.  Dispute Resolution.  (a)  Jurisdiction and Venue.   Notwithstanding any provision in your Employment Agreement, you and the Company hereby irrevocably submit to the exclusive jurisdiction of (i) the United States District Court for the Southern District of Texas and (ii) the courts of the State of Texas for the purposes of any action, suit or other proceeding arising out of this Award Agreement or the Plan.  You and the Company agree to commence any such action, suit or other proceeding either in the United States District Court for the Southern District of Texas or, if such action, suit or other proceeding may not be brought in such court for jurisdictional reasons, in the courts of the State of Texas.  You and the Company further agree that service of any process, summons, notice or document by U.S. registered mail to the applicable address set forth in Section 11 of this Award Agreement shall be effective service of process for any action, suit or other proceeding in Texas with respect to any matters to which you have submitted to jurisdiction in this Section 10(a).  You and the Company irrevocably and unconditionally waive any objection to the laying of venue of any action, suit or other proceeding arising out of this Award Agreement or the Plan in (A) the United States District Court for the Southern District of Texas or (B) the courts of the State of Texas, and hereby and thereby further irrevocably and unconditionally waive and agree not to plead or claim in any such court that any such action, suit or other proceeding brought in any such court has been brought in an inconvenient forum.

(b)  Waiver of Jury Trial.   You and the Company hereby waive, to the fullest extent permitted by applicable law, any right either of you may have to a trial by jury in respect to any litigation directly or indirectly arising out of, under or in connection with this Award Agreement or the Plan.

(c)  Confidentiality.    You hereby agree to keep confidential the existence of, and any information concerning, a dispute described in this Section 10, except that you may disclose information concerning such dispute to the court that is considering such dispute or to your legal counsel, accountants and other representatives (provided that such counsel, accountants and other representatives agree not to disclose any such information other than as necessary to the prosecution or defense of the dispute).

SECTION 11.  Notice.    All notices, requests, demands and other communications required or permitted to be given under the terms of this Award Agreement shall be in writing and shall be deemed to have been duly given when delivered by hand or overnight courier or three Business Days after they have been mailed by U.S. registered mail, return receipt requested, postage prepaid, addressed to the other party as set forth below:

If to the Company:

Benchmark Electronics, Inc.
3000 Technology Drive
Angleton, Texas 77515

Attention:  Legal Dept.

 

If to you:

To your address as most recently supplied to the Company and set forth in the Company’s records

 

5


 

 

 

The parties may change the address to which notices under this Award Agreement shall be sent by providing written notice to the other in the manner specified above.

SECTION 12.  G overning Law.   This Award Agreement shall be deemed to be made in the State of Texas, and the validity, construction and effect of this Award Agreement in all respects shall be determined in accordance with the laws of the State of Texas, without giving effect to the conflict of law principles thereof.

SECTION 13.  Headings and Construction.   Headings are given to the Sections and subsections of this Award Agreement solely as a convenience to facilitate reference. Such headings shall not be deemed in any way material or relevant to the construction or interpretation of this Award Agreement or any provision thereof.  Whenever the words “include”, “includes” or “including” are used in this Award Agreement, they shall be deemed to be followed by the words “but not limited to”. The term “or” is not exclusive.

SECTION 14.  Amendment of this Award Agreement.   The Committee may waive any conditions or rights under, amend any terms of, or alter, suspend, discontinue, cancel or terminate this Award Agreement prospectively or retroactively; provided , however , that any such waiver, amendment, alteration, suspension, discontinuance, cancelation or termination that would materially and adversely impair your rights under this Award Agreement shall not to that extent be effective without your consent (it being understood, notwithstanding the foregoing proviso, that this Award Agreement and the RSUs shall be subject to the provisions of Section 7(c) of the Plan).

SECTION 15.  Section 409A.   (a)  For purposes of Section 409A of the Code (“ Section 409A ”), it is intended that amounts payable pursuant to this Award Agreement qualify for the short-term deferral exception under Treas. Reg. Section 1.409A-1(b)(4) or any successor thereto, and all provisions of this Award Agreement shall be construed and interpreted in a manner consistent with such exception.

(b)  In the event that it is determined that any amounts payable pursuant to this Award Agreement do not qualify for the short-term deferral exception under Treas. Reg. Section 1.409A-1(b)(4) or any successor thereto, it is intended that the provisions of this Award Agreement comply with Section 409A, and all provisions of this Award Agreement shall be construed and interpreted in a manner consistent with the requirements for avoiding taxes or penalties under Section 409A and any similar state or local law.

(c)  Neither you nor any of your creditors or beneficiaries shall have the right to subject any deferred compensation (within the meaning of Section 409A) payable under this Award Agreement to any anticipation, alienation, sale, transfer, assignment,

6


 

 

pledge, encumbrance, attachment or garnishment.  Except as permitted under Section 409A, any deferred compensation (within the meaning of Section 409A) payable to you or for your benefit under this Award Agreement may not be reduced by, or offset against, any amount owing by you to the Company or any of its Subsidiaries.

(d)  To the extent required by Section 409A, any amount payable under the Award Agreement that constitutes deferred compensation (within the meaning of Section 409A) subject to, and not exempt from, Section 409A, payable or provided to you upon a termination of employment shall only be paid or provided to you upon your separation from service (within the meaning of Section 409A).  If, at the time of your separation from service, (i) you are a specified employee (within the meaning of Section 409A and using the identification methodology selected by the Company from time to time) and (ii) the Company shall make a good faith determination that an amount payable under this Award Agreement constitutes deferred compensation the payment of which is required to be delayed pursuant to the six-month delay rule set forth in Section 409A in order to avoid taxes or penalties under Section 409A, then the Company (or its Subsidiary, as applicable) shall not pay such amount on the otherwise scheduled payment date but shall instead accumulate such amount and pay it, without interest, on the first business day after such six-month period.

(e)  You shall be solely responsible and liable for the satisfaction of all taxes and penalties that may be imposed on you or for your account in connection with this Award Agreement (including any taxes and penalties under Section 409A), and neither the Company nor any of its Subsidiaries shall have any obligation to indemnify or otherwise hold you harmless from any or all such taxes or penalties.

SECTION 16.  Counterparts.    This Award Agreement may be signed in counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.

IN WITNESS WHEREOF, the parties have duly executed this Award Agreement as of the date first written above.

benchmark electronics, Inc.,

by

 

 

 

Name: 

 

Title:   

 

[NAME],

 

 

 

 

 

 

7


 

 

Exhibit 10.3

 

PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD AGREEMENT

Performance-Based Restricted Stock Unit Award Agreement under the Benchmark Electronics, Inc. 2010 Omnibus Incentive Compensation Plan dated as of ____________, between Benchmark Electronics, Inc. (the “ Company ”), a Texas corporation, and [NAME].

This Performance-Based Restricted Stock Unit Award Agreement (this “ Award Agreement ”) sets forth the terms and conditions of a target award (the “ Award ”) of _______ restricted stock units that are subject to the terms and conditions specified herein (“ RSUs ”) and that are being granted to you on the date hereof under the Benchmark Electronics, Inc. 2010 Omnibus Incentive Compensation Plan (the “ Plan ”).  Each RSU subject to this Award constitutes an unfunded and unsecured promise of the Company to deliver (or cause to be delivered) to you, subject to the terms of this Award Agreement, a share of the Company’s common stock, $0.10 par value (a “ Share ”), as set forth in Section 3 of this Award Agreement.

THIS AWARD IS SUBJECT TO ALL TERMS AND CONDITIONS OF THE PLAN AND THIS AWARD AGREEMENT, INCLUDING THE DISPUTE RESOLUTION PROVISIONS SET FORTH IN SECTION 10 OF THIS AWARD AGREEMENT.  BY SIGNING YOUR NAME BELOW, YOU SHALL HAVE CONFIRMED YOUR ACCEPTANCE OF THE TERMS AND CONDITIONS OF THIS AWARD AGREEMENT.

SECTION 1.  The Plan.   This Award is made pursuant to the Plan, all the terms of which are hereby incorporated in this Award Agreement.  In the event of any conflict between the terms of the Plan and the terms of this Award Agreement, the terms of the Plan shall govern.  In the event of any conflict between the terms of this Award Agreement and the terms of any individual employment agreement between you and the Company or any of its Subsidiaries (an “ Employment Agreement ”), the terms of your Employment Agreement shall govern.

SECTION 2.  Definitions.    Capitalized terms used in this Award Agreement that are not defined in this Award Agreement have the meanings as used or defined in the Plan.  As used in this Award Agreement, the following terms have the meanings set forth below:

(a)  Business Day ” means a day that is not a Saturday, a Sunday or a day on which banking institutions are legally permitted to be closed in the City of New York.

(b)  Cause ” means the occurrence of any one of the following:

(i)  your gross negligence in the performance of your duties with the Company, which gross negligence results in a material adverse effect on the

1


 

Company, provided that no such gross negligence shall constitute “Cause” if it relates to an action taken or omitted by you in the good faith, reasonable belief that such action or omission was in or not opposed to the best interests of the Company;

(ii)  your habitual neglect or disregard of your duties with the Company that is materially and demonstrably injurious to the Company, after written notice from the Company stating the duties you have failed to perform;

(iii)  your engaging in conduct or misconduct that materially harms the reputation or financial position of the Company;

(iv)  your obstruction, impedance or failure to materially cooperate with an investigation authorized by the Board, a self-regulatory organization empowered with self-regulatory responsibilities under Federal or state laws, or a governmental department or agency; or

(v)  your conviction of a felony, provided that no such conviction will constitute “Cause” if it relates to an action taken or omitted by you in the good faith, reasonable belief that such action or omission was in or not opposed to the best interests of the Company.

(c)  Good Reason ” means the occurrence of any one of the following:

(i)  a material diminution of your duties or responsibilities;

(ii)  a greater than 10% reduction in your base salary, annual bonus opportunity or long-term incentive compensation opportunity; or

(iii)  a material breach by the Company of any provision of your Employment Agreement or any other agreement between you and the Company.

A termination of your employment by you for Good Reason shall be effectuated by giving the Company written notice (“ Notice of Termination for Good Reason ”), not later than 90 days following the date of the occurrence of the circumstance that constitutes Good Reason, setting forth in reasonable detail the specific conduct of the Company or any of its Subsidiaries that constitutes Good Reason and the specific provisions of this Award Agreement, your Employment Agreement or any other agreement between you and the Company on which you relied.  The Company shall be entitled, during the 30-day period following receipt of a Notice of Termination for Good Reason, to cure the circumstances that gave rise to Good Reason, provided that the Company shall be entitled to waive its right to cure or reduce the cure period by delivery of written notice to that effect to you (such 30-day or shorter period, the “ Cure Period ”).  If, during the Cure Period, such circumstance is remedied, you shall not be permitted to terminate your employment for Good Reason as a result of such circumstance.  If, at the end of the Cure Period, the circumstance that constitutes Good Reason has not been remedied, you shall be entitled to terminate your employment for Good Reason during the 90-day period that follows the end of the Cure Period (the “ Termination Period ”).  If you do not terminate

2


 

your employment during the Termination Period, you shall not be permitted to terminate your employment for Good Reason as a result of such circumstance.

 

(d)  Payment Formula ” means the formula set forth in ________ that determines the number of RSUs that shall vest pursuant to this Award Agreement based on whether, or the extent to which, the Performance Goals are achieved.

(e)  Performance Goals ” means the goals set forth in ________ A, the achievement of which determine the number of RSUs that shall vest pursuant to this Award Agreement.

(f)  Performance Period ” means the period of time specified in ________ A, over which the achievement of the Performance Goals shall be measured.

SECTION 3.  Vesting and Delivery.   (a)  Performance-Based Vesting.  
Except as otherwise provided in your Employment Agreement or Section 3(b) of this Award Agreement, the vesting of your rights with respect to the RSUs shall be contingent on the achievement of the Performance Goals as set forth in Attachment A.  Accordingly, unless otherwise provided in your Employment Agreement or Section 3(b) of this Award Agreement, your rights with respect to the RSUs subject to this Award Agreement shall not become vested unless and until the Committee, in its sole discretion, determines whether, or the extent to which, the Performance Goals have been achieved.  As soon as reasonably practicable following the end of the Performance Period and in no event later than March 15 of the calendar year following the calendar year in which the Performance Period ends, the Committee shall determine whether, or the extent to which, the Performance Goals have been achieved (the date of such determination, the “
Determination Date ”) and shall provide notice to you of such determination as soon as reasonably practicable following such determination in accordance with Section 11 of this Award Agreement.  Upon such determination by the Committee and subject to the provisions of the Plan and this Award Agreement (including Section 3(c) of this Award Agreement), you shall vest in that percentage of the target number of RSUs that is determined pursuant to the Payment Formula set forth in ________.  Notwithstanding the foregoing, pursuant to Section 4 of this Award Agreement and except as otherwise provided in your Employment Agreement or Section 3(b) of this Award Agreement, in order for your rights with respect to any RSUs to become vested, you must be employed by the Company or one of its Subsidiaries on the last day of the Performance Period and by March 15 th of the following calendar year.

(b)  Vesting following a Change of Control.   If, during the two-year period immediately following a Change of Control, your employment is terminated by the Company or any of its Subsidiaries without Cause or you terminate your employment for Good Reason on or prior to the last day of the Performance Period, then you shall vest in 100% of the target number of RSUs set forth in ________, and the date of such termination of employment shall be deemed to be the Determination Date.

(c)  Negative Discretion.  This Award is intended to constitute a Performance Compensation Award that qualifies as “qualified performance-based

3


 

compensation” under Section 162(m) of the Code and, therefore, is subject to all provisions of Section 6(e) of the Plan, including the Committee’s authority to reduce or eliminate the number of RSUs awarded to you pursuant to this Award Agreement, even if the Performance Goals have been achieved and without regard to your Employment Agreement.

(d)  Delivery of Shares.   As soon as reasonably practicable following the Determination Date and in no event later than March 15 of the calendar year following the calendar year in which (i) the Performance Period ends or (ii) in the event Section 3(b) of this Award Agreement applies, the Determination Date occurs, the Company shall deliver to you one Share for each RSU awarded to you pursuant to this Award Agreement that has vested in accordance with the terms of this Award Agreement, subject to tax withholding provisions of Section 7 (a) below.

(e)  Equity Ownership Policy .  Because the Company believes that stock ownership by senior management further aligns their interest with the interests of the company’s shareholders, the Company has established an equity ownership policy for certain of senior management.  According to that policy, the Company expects you to retain 20% of each vesting of RSUs until you own during the term of your employment with the Company shares of stock having a market value equal to _______ times your annual base salary (such salary measured as of January 1 st of the year of the Vesting Date).

SECTION 4.  Forfeiture of RSUs.   Unless the Committee determines otherwise, and except as otherwise provided in your Employment Agreement or Section 3(b) of this Award Agreement, if your rights with respect to any RSUs awarded to you pursuant to this Award Agreement have not become vested prior to the date on which your employment with the Company and its Subsidiaries terminates, your rights with respect to such RSUs shall immediately terminate, and you shall be entitled to no further payments or benefits with respect thereto.

SECTION 5.  Voting Rights; Dividend Equivalents.   Prior to the date on which Shares are delivered to you in settlement of the RSUs pursuant to this Award Agreement, you shall not be entitled to exercise any voting rights with respect to the Shares underlying such RSUs and shall not be entitled to receive dividends or other distributions with respect to such Shares.

SECTION 6.  Non-Transferability of RSUs.   Unless otherwise provided by the Committee in its discretion, RSUs may not be sold, assigned, alienated, transferred, pledged, attached or otherwise encumbered except as provided in Section 9(a) of the Plan.  Any purported sale, assignment, alienation, transfer, pledge, attachment or other encumbrance of an RSU in violation of the provisions of this Section 6 and Section 9(a) of the Plan shall be void.

SECTION 7.  Withholding, Consents and Legends.   (a)  Withholding.    The delivery of Shares pursuant to Section 3 of this Agreement is conditioned on satisfaction of any applicable withholding taxes in accordance with Section 9(d) of the Plan.  In the

4


 

event that there is withholding tax liability in connection with the settlement of RSUs, you may satisfy, in whole or in part, any withholding tax liability by having the Company withhold from the Shares you would be entitled to receive upon settlement of the RSUs a number of Shares having a Fair Market Value (which shall either have the meaning set forth in the Plan or shall have such other meaning as determined by the Company in accordance with applicable withholding requirements) equal to such withholding tax liability; provided, however, that if you are an officer subject to Section 16 of the Exchange Act, such withholding tax liability shall be satisfied by the Company withholding such number of Shares from the Shares you would be entitled to receive upon settlement of the RSUs, without any election on your part.

(b)  Consents; Compliance with Law.   Your rights in respect of the RSUs are conditioned on the receipt to the full satisfaction of the Committee of any required consents that the Committee may determine to be necessary or advisable (including your consenting to the Company’s supplying to any third-party record-keeper of the Plan such personal information as the Committee deems advisable to administer the Plan) and, in accordance with Section 9(l) of the Plan, subject to the Committee’s determination that the issuance of Shares pursuant to this Award Agreement is compliant with applicable law.

(c)  Legends.    The Company may affix to certificates for Shares issued pursuant to this Award Agreement any legend that the Committee determines to be necessary or advisable (including to reflect any restrictions to which you may be subject under any applicable securities laws).  The Company may advise the transfer agent to place a stop order against any legended Shares.

SECTION 8.  Successors and Assigns of the Company.   The terms and conditions of this Award Agreement shall be binding upon and shall inure to the benefit of the Company and its successors and assigns.

SECTION 9.  Committee Discretion.   Subject to the terms of this Award Agreement and your Employment Agreement, the Committee shall have discretion with respect to any actions to be taken or determinations to be made in connection with this Award Agreement, and its determinations shall be final, binding and conclusive.

SECTION 10.  Dispute Resolution.   (a)  Jurisdiction and Venue.   Notwithstanding any provision in your Employment Agreement, you and the Company hereby irrevocably submit to the exclusive jurisdiction of (i) the United States District Court for the Southern District of Texas and (ii) the courts of the State of Texas for the purposes of any action, suit or other proceeding arising out of this Award Agreement or the Plan.  You and the Company agree to commence any such action, suit or other proceeding either in the United States District Court for the Southern District of Texas or, if such action, suit or other proceeding may not be brought in such court for jurisdictional reasons, in the courts of the State of Texas.  You and the Company further agree that service of any process, summons, notice or document by U.S. registered mail to the applicable address set forth in Section 11 of this Award Agreement shall be effective service of process for any action, suit or other proceeding in Texas with respect to any

5


 

matters to which you have submitted to jurisdiction in this Section 10(a).  You and the Company irrevocably and unconditionally waive any objection to the laying of venue of any action, suit or other proceeding arising out of this Award Agreement or the Plan in (A) the United States District Court for the Southern District of Texas or (B) the courts of the State of Texas, and hereby and thereby further irrevocably and unconditionally waive and agree not to plead or claim in any such court that any such action, suit or other proceeding brought in any such court has been brought in an inconvenient forum.

(b)  Waiver of Jury Trial.   You and the Company hereby waive, to the fullest extent permitted by applicable law, any right either of you may have to a trial by jury in respect to any litigation directly or indirectly arising out of, under or in connection with this Award Agreement or the Plan.

(c)  Confidentiality.    You hereby agree to keep confidential the existence of, and any information concerning, a dispute described in this Section 10, except that you may disclose information concerning such dispute to the court that is considering such dispute or to your legal counsel, accountants and other representatives (provided that such counsel, accountants and other representatives agree not to disclose any such information other than as necessary to the prosecution or defense of the dispute).

SECTION 11.  Notice.    All notices, requests, demands and other communications required or permitted to be given under the terms of this Award Agreement shall be in writing and shall be deemed to have been duly given when delivered by hand or overnight courier or three Business Days after they have been mailed by U.S. registered mail, return receipt requested, postage prepaid, addressed to the other party as set forth below:

If to the Company:

Benchmark Electronics, Inc.
3000 Technology Drive
Angleton, Texas 77515

Attention:  General Counsel

 

If to you:

To your address as most recently supplied to the Company and set forth in the Company’s records

 

 

The parties may change the address to which notices under this Award Agreement shall be sent by providing written notice to the other in the manner specified above.

SECTION 12.  G overning Law.   This Award Agreement shall be deemed to be made in the State of Texas, and the validity, construction and effect of this Award Agreement in all respects shall be determined in accordance with the laws of the State of Texas, without giving effect to the conflict of law principles thereof.

SECTION 13.  Headings and Construction.   Headings are given to the Sections and subsections of this Award Agreement solely as a convenience to facilitate

6


 

reference. Such headings shall not be deemed in any way material or relevant to the construction or interpretation of this Award Agreement or any provision thereof.  Whenever the words “include”, “includes” or “including” are used in this Award Agreement, they shall be deemed to be followed by the words “but not limited to”.  The term “or” is not exclusive.

SECTION 14.  Amendment of this Award Agreement.   The Committee may waive any conditions or rights under, amend any terms of, or alter, suspend, discontinue, cancel or terminate this Award Agreement prospectively or retroactively; provided , however , that any such waiver, amendment, alteration, suspension, discontinuance, cancelation or termination that would materially and adversely impair your rights under this Award Agreement shall not to that extent be effective without your consent (it being understood, notwithstanding the foregoing proviso, that this Award Agreement and the RSUs shall be subject to the provisions of Section 7(c) of the Plan).

SECTION 15.  Section 409A.   (a)  For purposes of Section 409A of the Code (“ Section 409A ”), it is intended that amounts payable pursuant to this Award Agreement qualify for the short-term deferral exception under Treas. Reg. Section 1.409A-1(b)(4) or any successor thereto, and all provisions of this Award Agreement shall be construed and interpreted in a manner consistent with such exception.

(b)  In the event that it is determined that any amounts payable pursuant to this Award Agreement do not qualify for the short-term deferral exception under Treas. Reg. Section 1.409A-1(b)(4) or any successor thereto, it is intended that the provisions of this Award Agreement comply with Section 409A, and all provisions of this Award Agreement shall be construed and interpreted in a manner consistent with the requirements for avoiding taxes or penalties under Section 409A and any similar state or local law.

(c)  Neither you nor any of your creditors or beneficiaries shall have the right to subject any deferred compensation (within the meaning of Section 409A) payable under this Award Agreement to any anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, attachment or garnishment.  Except as permitted under Section 409A, any deferred compensation (within the meaning of Section 409A) payable to you or for your benefit under this Award Agreement may not be reduced by, or offset against, any amount owing by you to the Company or any of its Subsidiaries.

(d)  To the extent required by Section 409A, any amount payable under the Award Agreement that constitutes deferred compensation (within the meaning of Section 409A) subject to, and not exempt from, Section 409A, payable or provided to you upon a termination of employment shall only be paid or provided to you upon your separation from service (within the meaning of Section 409A).  If, at the time of your separation from service, (i) you are a specified employee (within the meaning of Section 409A and using the identification methodology selected by the Company from time to time) and (ii) the Company shall make a good faith determination that an amount payable under this Award Agreement constitutes deferred compensation the payment of which is required to be delayed pursuant to the six-month delay rule set forth in

7


 

Section 409A in order to avoid taxes or penalties under Section 409A, then the Company (or its Subsidiary, as applicable) shall not pay such amount on the otherwise scheduled payment date but shall instead accumulate such amount and pay it, without interest, on the first business day after such six-month period.

(e)  You shall be solely responsible and liable for the satisfaction of all taxes and penalties that may be imposed on you or for your account in connection with this Award Agreement (including any taxes and penalties under Section 409A), and neither the Company nor any of its Subsidiaries shall have any obligation to indemnify or otherwise hold you harmless from any or all such taxes or penalties.

SECTION 16.  Counterparts.    This Award Agreement may be signed in counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.

IN WITNESS WHEREOF, the parties have duly executed this Award Agreement as of the date first written above.

benchmark electronics, Inc.,

by

 

 

 

Name:

 

Title:

 

  

 

 

 

         

NAME /Date

 

 

8


 

 

Exhibit 31.1

 

Section 302 Certification of Chief Executive Officer

 

I, Paul J. Tufano, certify that:

 

1.        I have reviewed this quarterly report on Form 10-Q of Benchmark Electronics, Inc.;

 

2.        Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.        Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.        Benchmark’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for Benchmark and have:

 

(a)      Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to Benchmark, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)      Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)      Evaluated the effectiveness of Benchmark’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)      Disclosed in this report any change in Benchmark’s internal control over financial reporting that occurred during Benchmark’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, Benchmark’s internal control over financial reporting; and

 

5.        Benchmark’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to Benchmark’s auditors and the audit committee of Benchmark’s board of directors (or persons performing the equivalent functions):

 

(a)      All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect Benchmark’s ability to record, process, summarize and report financial information; and

 

(b)      Any fraud, whether or not material, that involves management or other employees who have a significant role in Benchmark’s internal control over financial reporting.

 

 

By: /s/ Paul J. Tufano

 

Paul J. Tufano

 

President and Chief Executive Officer

 

May 8, 2017

 

 


 

 

Exhibit 31.2

 

Section 302 Certification of Chief Financial Officer

 

I, Donald F. Adam, certify that:

 

1.        I have reviewed this quarterly report on Form 10-Q of Benchmark Electronics, Inc.;

 

2.        Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.        Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.        Benchmark’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for Benchmark and have:

 

(a)      Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to Benchmark, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)      Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)      Evaluated the effectiveness of Benchmark’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)      Disclosed in this report any change in Benchmark’s internal control over financial reporting that occurred during Benchmark’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, Benchmark’s internal control over financial reporting; and

 

5.        Benchmark’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to Benchmark’s auditors and the audit committee of Benchmark’s board of directors (or persons performing the equivalent functions):

 

(a)      All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect Benchmark’s ability to record, process, summarize and report financial information; and

 

(b)      Any fraud, whether or not material, that involves management or other employees who have a significant role in Benchmark’s internal control over financial reporting.

  

 

 

By: /s/ Donald F. Adam

 

Donald F. Adam

 

Chief Financial Officer

 

May 8, 2017

 

 


 

 

Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
(Section 906 of the Sarbanes-Oxley Act of 2002)

 

In connection with the Quarterly Report of Benchmark Electronics, Inc. (the Company) on Form 10-Q for the period ending March 31, 2017 (the Report), I certify to the best of my knowledge that:

 

(1)      The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2)      The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

By: /s/ Paul J. Tufano

 

Paul J. Tufano

 

President and Chief Executive Officer

 

May 8, 2017

 

 


 

 

Exhibit 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
(Section 906 of the Sarbanes-Oxley Act of 2002)

 

In connection with the Quarterly Report of Benchmark Electronics, Inc. (the Company) on Form 10-Q for the period ending March 31, 2017 (the Report), I certify to the best of my knowledge that:

 

(1)      The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2)      The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

By: /s/ Donald F. Adam

 

Donald F. Adam

 

Chief Financial Officer

 

May 8, 2017